Crown (CCK) 10-K 26 Feb 21 2020 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2020	Feb. 24, 2021	Jun. 30, 2020
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	000-50189
Entity Registrant Name	CROWN HOLDINGS, INC.
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	75-3099507
Entity Address, Address Line One	770 Township Line Road
Entity Address, City or Town	Yardley
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19067-4232
City Area Code	215
Local Phone Number	698-5100
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 8,777,604,424
Entity Common Stock, Shares Outstanding		134,936,129
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Document Parts Into Which Incorporated Proxy Statement for the Annual Meeting of Shareholders to be held April 22, 2021 Part III to the extent described therein
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Central Index Key	0001219601
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock $5.00 Par Value
Trading Symbol	CCK
Security Exchange Name	NYSE
7 3/8% Debentures Due 2026
Document Information [Line Items]
Title of 12(b) Security	7 3/8% Debentures Due 2026
Trading Symbol	CCK26
Security Exchange Name	NYSE
7 1/2% Debentures Due 2096
Document Information [Line Items]
Title of 12(b) Security	7 1/2% Debentures Due 2096
Trading Symbol	CCK96
Security Exchange Name	NYSE

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Net sales	$ 11,575	$ 11,665	$ 11,151
Cost of products sold, excluding depreciation and amortization	9,182	9,349	9,028
Depreciation and amortization	481	490	425
Selling and administrative expense	614	631	558
Restructuring and other	34	(26)	44
Goodwill impairment	0	25	0
Income from operations	1,264	1,196	1,096
Loss from early extinguishments of debt	0	27	0
Other pension and postretirement	45	13	(25)
Interest expense	300	378	384
Interest income	(8)	(17)	(21)
Foreign exchange	1	9	18
Income before income taxes	926	786	740
Provision for income taxes	244	166	216
Equity in net earnings of affiliates	6	5	4
Net income	688	625	528
Net income attributable to noncontrolling interests	(109)	(115)	(89)
Net income attributable to Crown Holdings	$ 579	$ 510	$ 439
Earnings per common share attributable to Crown Holdings:
Basic (in dollars per share)	$ 4.34	$ 3.81	$ 3.28
Diluted (in dollars per share)	$ 4.30	$ 3.78	$ 3.28

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 688	$ 625	$ 528
Other comprehensive (loss) / income, net of tax
Foreign currency translation adjustments	(88)	150	(137)
Pension and other postretirement benefits	(15)	84	50
Derivatives qualifying as hedges	46	11	(52)
Total other comprehensive (loss) / income	(57)	245	(139)
Total comprehensive income	631	870	389
Net income attributable to noncontrolling interests	(109)	(115)	(89)
Translation adjustments attributable to noncontrolling interests	(3)	(1)	1
Derivatives qualifying as hedges attributable to noncontrolling interests	(2)	(1)	2
Comprehensive income attributable to Crown Holdings	$ 517	$ 753	$ 303

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 1,173	$ 607
Receivables, net	1,783	1,528
Inventories	1,673	1,626
Prepaid expenses and other current assets	254	241
Total current assets	4,883	4,002
Goodwill	4,593	4,430
Intangible assets	1,880	2,015
Property, plant and equipment, net	4,198	3,887
Operating lease right-of-use assets	214	204
Other non-current assets	902	967
Total	16,670	15,505
Current liabilities
Short-term debt	121	75
Current maturities of long-term debt	67	62
Current portion of operating lease liabilities	55	51
Accounts payable	2,845	2,646
Accrued liabilities	1,173	1,065
Total current liabilities	4,261	3,899
Long-term debt, excluding current maturities	8,023	7,818
Postretirement and pension liabilities	762	683
Non-current portion of operating lease liabilities	164	156
Other non-current liabilities	856	857
Commitments and contingent liabilities (Note O)
Equity
Noncontrolling interests	406	379
Preferred stock, authorized: 30,000,000; none issued (Note S)	0	0
Common stock, par value: $5.00; authorized: 500,000,000 shares; issued: 185,744,072 shares (Note T)	929	929
Additional paid-in capital	179	207
Accumulated earnings	4,538	3,959
Accumulated other comprehensive loss	(3,193)	(3,131)
Treasury stock at par value (2020 - 50,943,042 shares; 2019 - 50,166,194 shares)	(255)	(251)
Crown Holdings shareholders’ equity	2,198	1,713
Total equity	2,604	2,092
Total	$ 16,670	$ 15,505

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, shares authorized (in shares)	30,000,000	30,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in usd per share)	$ 5	$ 5
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	185,744,072	185,744,072
Treasury stock (in shares)	50,943,042	50,166,194

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities
Net income	$ 688	$ 625	$ 528
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	481	490	425
Restructuring and other	34	(26)	44
Goodwill impairment	0	25	0
Pension expense	92	66	45
Pension contributions	(27)	(23)	(20)
Stock-based compensation	32	29	27
Deferred income taxes	33	(35)	35
Changes in assets and liabilities:
Receivables	(186)	60	(493)
Inventories	(2)	61	(201)
Accounts payable and accrued liabilities	121	(87)	209
Other, net	49	(22)	(28)
Net cash provided by operating activities	1,315	1,163	571
Cash flows from investing activities
Capital expenditures	(587)	(432)	(462)
Beneficial interest in transferred receivables	0	0	490
Acquisition of businesses, net of cash acquired	0	(11)	(3,912)
Foreign exchange derivatives related to acquisition	0	0	(25)
Net investment hedges	28	23	34
Proceeds from sale of property, plant and equipment	16	39	36
Other	8	7	(4)
Net cash used for investing activities	(535)	(374)	(3,843)
Cash flows from financing activities
Net change in revolving credit facility and short-term debt	29	(10)	(69)
Proceeds from long-term debt	110	2,216	4,082
Payments of long-term debt	(269)	(2,845)	(333)
Debt issuance costs	0	(18)	(70)
Foreign exchange derivatives related to debt	43	(16)	(14)
Finance lease payments	(3)	(15)	0
Dividends paid to noncontrolling interests	(87)	(101)	(60)
Contribution from noncontrolling interests	2	6	0
Common stock issued	2	4	1
Common stock repurchased	(66)	(7)	(4)
Net cash (used for) / provided by financing activities	(239)	(786)	3,533
Effect of exchange rate changes on cash, cash equivalents and restricted cash	34	1	(37)
Net change in cash, cash equivalents and restricted cash	575	4	224
Cash and cash equivalents at beginning of period	663	659	435
Cash and cash equivalents at end of period	$ 1,238	$ 663	$ 659

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Paid-in Capital	Accumulated Earnings	Accumulated EarningsCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive LossCumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Total Crown Equity	Total Crown EquityCumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interests	Noncontrolling InterestsCumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period at Dec. 31, 2017	$ 923	$ 10	$ 929	$ 167	$ 3,004	$ 6	$ (3,241)	$ 3	$ (258)	$ 601	$ 9	$ 322	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	528				439					439		89
Other comprehensive income (loss)	(139)						(136)			(136)		(3)
Dividends paid to noncontrolling interests	(60)											(60)
Restricted stock awarded				(5)					5
Stock-based compensation	27			27						27
Common stock issued	1			1						1
Common stock repurchased	(4)			(4)						(4)
Balance at end of period at Dec. 31, 2018	1,286		929	186	3,449		(3,374)		(253)	937		349
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	625				510					510		115
Other comprehensive income (loss)	245						243			243		2
Dividends paid to noncontrolling interests	(101)											(101)
Restricted stock awarded				(2)					2
Contribution from noncontrolling interests	10											10
Sale of noncontrolling interests	1			(3)						(3)		4
Stock-based compensation	29			29						29
Common stock issued	4			4						4
Common stock repurchased	(7)			(7)						(7)
Balance at end of period at Dec. 31, 2019	2,092		929	207	3,959		(3,131)		(251)	1,713		379
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	688				579					579		109
Other comprehensive income (loss)	(57)						(62)			(62)		5
Dividends paid to noncontrolling interests	(87)											(87)
Restricted stock awarded				(2)					2
Stock-based compensation	32			32						32
Common stock issued	2			2						2
Common stock repurchased	(66)			(60)					(6)	(66)
Balance at end of period at Dec. 31, 2020	$ 2,604		$ 929	$ 179	$ 4,538		$ (3,193)		$ (255)	$ 2,198		$ 406

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business and Principles of Consolidation . The consolidated financial statements include the accounts of Crown Holdings, Inc. (the “Company”) and its consolidated subsidiary companies (where the context requires, the “Company” shall include reference to the Company and its consolidated subsidiary companies). The Company is a worldwide leader in the design, manufacture and sale of packaging products and equipment for consumer goods and industrial products. The Company’s packaging for consumer goods include steel and aluminum cans for beverage, food, household and other consumer products, glass bottles for beverage products and metal vacuum closures and steel crowns sold through the Company's sales organization to the soft drink, food, citrus, brewing, household products, personal care and various other industries. The Company's packaging for industrial products includes steel and plastic strap consumables and equipment, paper-based protective packaging, and plastic film consumables and equipment, which are sold into the metals, food and beverage, construction, agricultural, corrugated and general industries. The financial statements were prepared in conformity with accounting principles generally accepted in the United States of America and reflect management’s estimates and assumptions. Actual results could differ from those estimates, impacting reported results of operations and financial position. All intercompany accounts and transactions are eliminated in consolidation. In deciding which entities should be reported on a consolidated basis, the Company first determines whether the entity is a variable interest entity (“VIE”). If an entity is a VIE, the Company determines whether it is the primary beneficiary and therefore, should consolidate the VIE. If an entity is not a VIE, the Company consolidates those entities in which it has control, including certain subsidiaries that are not majority-owned. Certain of the Company’s agreements with noncontrolling interests contain provisions in which the Company would surrender certain decision-making rights upon a change in control of the Company. Accordingly, consolidation of these operations may no longer be appropriate subsequent to a change in control of the Company, as defined in the agreements. Investments in companies in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are carried at cost. Foreign Currency Translation . For non-U.S. subsidiaries which operate in a local currency environment, assets and liabilities are translated into U.S. dollars at year-end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the year. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired; all other assets and liabilities are translated at year-end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates; all other income and expense items are translated at average exchange rates prevailing during the year. Gains and losses which result from remeasurement are included in earnings. Revenue Recognition . On January 1, 2018, the Company adopted new accounting guidance which outlined a single comprehensive model to use in accounting for revenue arising from contracts with customers and superseded previous revenue guidance. Under previous guidance, the Company generally recognized revenue from product sales when the goods were shipped and title and risk of loss passed to the customer. Under the new guidance, revenues are recognized when control of the promised product is transferred to customers. The majority of the Company’s revenues from metal packaging products are derived from multi-year requirement contracts with leading manufacturers and marketers of packaged consumer products for can sets, comprising a can and an end. As requirement contracts do not typically include fixed volumes, customers often purchase products pursuant to purchase orders or other communications which are short-term in nature. The can and the end are considered separate performance obligations because they are distinct and separately identifiable. Revenues from the Company's transit packaging segment are generally derived from individual purchase orders which may include multiple goods and services which are separate performance obligations because they are distinct and separately identifiable. The Company manufactures certain products that have no alternative use to the Company once they are printed or manufactured to customer specifications. If the Company has an enforceable right to payment for custom products at all times in the manufacturing process, revenue is recognized over time. In each of the Company’s geographic markets, revenue from beverage cans is primarily recognized over time using the units produced output method as beverage cans are generally printed for a specific customer in a continuous production process. The timing of revenue recognition for the Company’s other products, including beverage ends and three-piece products, which includes food cans and ends and aerosol cans and ends, may vary as these products may be printed or customized depending upon customer preferences which can vary by geographic market. Revenue that is recognized over time for the Company’s three-piece products and equipment business is generally recognized using the cost-to-cost input method as these products involve an intermediary step that results in customized work-in-process inventory. For products that follow a point in time model, revenue is generally recognized when title and risk of loss transfer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Standalone selling prices for each performance obligation are generally stated in the contract. When the Company offers variable consideration in the form of volume rebates to customers, it estimates the most likely amount of revenue to which it is expected to be entitled and includes the estimate in the transaction price, limited to the amount which is probable will not result in reversal of cumulative revenue recognized when the variable consideration is resolved. When the Company offers customers options to purchase additional product at discounted prices, judgment is required to determine if the discounted prices represent material rights. If so, the transaction price allocated to the discount is based on its relative standalone price and is recognized upon purchase of the additional product. Customer payment terms are typically less than one year and as such, the Company has applied the practical expedient to exclude consideration of significant financing components from the determination of transaction price. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Shipping and handling fees and costs from product sales are reported as cost of products sold and are accrued when the Company recognizes revenue over time before the shipping and handling activities occur. Costs to obtain a contract are generally immaterial but the Company has elected the practical expedient to expense these costs as incurred if the duration of the contract is one year or less. Unbilled receivables are recorded for revenue recognized over time when the Company has determined that control has passed to the customer but the customer has not yet been invoiced because the Company does not have present right to payment. The Company generally has a present right to payment when title of product transfers. Unbilled receivables are included in receivables in the Consolidated Balance Sheet with a corresponding decrease to inventory. Contract assets are recorded for revenue recognized over time when the Company has determined that control for a performance obligation has passed to the customer, but the right to invoice the customer is contingent upon the completion of the performance obligations included in the contract. Contract assets are classified as current as they are expected to be invoiced within one year and may not exceed their net realizable value. Contract liabilities are established if the Company must defer the recognition of a portion of consideration received because it has to satisfy a future obligation. Contract liabilities are classified as current or noncurrent based on when the Company expects to recognize revenue. Stock-Based Compensation . For awards with a service or market condition, compensation expense is recognized over the vesting period on a straight-line basis using the grant date fair value of the award and the estimated number of awards that are expected to vest. For awards with a performance condition, the Company assesses the probability of vesting at each reporting period and adjusts compensation cost based on its probability assessment. The Company’s plans provide for stock awards which may include accelerated vesting upon retirement, disability, or death of eligible employees. The Company considers a stock-based award to be vested when the service period is no longer contingent on the employee providing future service. Accordingly, the related compensation cost is recognized immediately for awards granted to retirement-eligible individuals, or over the period from the grant date to the date that retirement eligibility is achieved if less than the stated vesting period. Cash, Cash Equivalents and Restricted Cash . Cash equivalents represent investments with maturities of three months or less from the time of purchase and are carried at cost, which approximates fair value because of the short maturity of those instruments. Outstanding checks in excess of funds on deposit are included in accounts payable. The Company generally classifies any cash that is legally restricted as to withdrawal or usage as restricted cash. Accounts Receivable and Allowance for Credit Losses. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The measurement of expected credit losses is based on past events, historical experience, current conditions and forecasts that affect the collectability of accounts receivable. Inventory Valuation . Inventories are stated at the lower of cost or net realizable value, with cost principally determined under the first-in, first-out (“FIFO”) or average cost method. Property, Plant and Equipment . Property, plant and equipment (“PP&E”) is carried at cost less accumulated depreciation and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. Cost of constructed assets includes capitalized interest incurred during the construction and development period. Maintenance and repairs, including labor and material costs for planned major maintenance such as annual production line overhauls, are expensed as incurred. When PP&E is retired or otherwise disposed, the net carrying amount is eliminated with any gain or loss on disposition recognized in earnings at that time. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18 Goodwill and Intangible Assets . Assets and liabilities of acquired businesses are recorded under the acquisition method of accounting at their estimated fair values at the dates of acquisition. Goodwill represents costs in excess of fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is carried at cost and reviewed for impairment annually in the fourth quarter of each year or when facts and circumstances indicate goodwill may be impaired. Goodwill was allocated to the reporting units at the time of each acquisition based on the relative fair values of the reporting units. In assessing goodwill for impairment, the Company may first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Further quantitative assessment may then be required. The quantitative assessment involves a number of assumptions and judgments, including the calculation of fair value for the Company’s identified reporting units. The Company determines the estimated fair value of each reporting unit based on an average of the estimated fair values using an income and a market approach. The income approach utilizes significant assumptions, including revenue and Adjusted EBITDA margin growth rates and discount rate. If the carrying value of a reporting unit exceeds its fair value, any impairment loss is measured by comparing the carrying value of the reporting unit to its fair value, not to exceed the carrying amount of goodwill. Definite-lived intangible assets are carried at cost less accumulated amortization. Definite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Definite-lived intangible assets are tested for impairment when facts and circumstances indicate the carrying value may not be recoverable from their undiscounted cash flows. If impaired, the assets are written down to fair value based on either discounted cash flows or appraised values. Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Impairment or Disposal of Long-Lived Assets . In the event that facts and circumstances indicate that the carrying value of long-lived assets, primarily PP&E, may be impaired, the Company performs a recoverability evaluation. If the evaluation indicates that the carrying value of an asset is not recoverable from its undiscounted cash flows, an impairment loss is measured by comparing the carrying value of the asset to its fair value, based on discounted cash flows. Long-lived assets classified as held for sale are presented in the balance sheet at the lower of their carrying value or fair value less cost to sell. Leases. On January 1, 2019, the Company adopted new guidance on lease accounting. Under the guidance, lease classification criteria and income statement recognition were similar to previous guidance; however, all leases with a term longer than one year are recorded on the balance sheet through a right-of-use asset and a corresponding liability. The Company has operating and finance leases for land and buildings related to certain manufacturing facilities, warehouses and corporate offices, vehicle fleets and certain office and manufacturing equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company's lease terms include options to extend the lease when it is reasonably certain that the Company will exercise the option. Variable lease payment amounts that cannot be determined at commencement of the lease, such as increases in index rates, are not included in the measurement of the lease liabilities and corresponding right-of-use assets and are recognized in the period those payments are incurred. The Company separates lease and non-lease components of lease arrangements and allocates contract consideration based on standalone selling prices. Variable consideration is allocated to the lease and non-lease components to which the variable payments specifically relate. The discount rate implicit within the Company's leases is often not determinable and therefore the Company generally uses its incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of the lease payments. The incremental borrowing rate is determined based on lease term and the currency in which lease payments are made. The Company's leases do not contain any material residual value guarantees or material restrictive covenants. Taxes on Income . The provision for income taxes is determined using the asset and liability approach. Deferred taxes represent the future expected tax consequences of differences between the financial reporting and tax bases of assets and liabilities based upon enacted tax rates and laws. The Company has made an accounting policy election to treat taxes due on future U.S. inclusions of certain intangible income of foreign subsidiaries as a current period expense when incurred. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Investment tax credits are accounted for using the deferral method. Income tax-related interest and penalties are reported as income tax expense. Derivatives and Hedging . All outstanding derivative financial instruments are recognized in the balance sheet at their fair values. The impact on earnings from recognizing the fair values of these instruments depends on their intended use, their hedge designation and their effectiveness in offsetting changes in the fair values of the exposures they are hedging. Changes in the fair values of instruments designated to reduce or eliminate adverse fluctuations in the fair values of recognized assets and liabilities are reported currently in earnings along with changes in the fair values of the hedged items. Changes in the effective portions of the fair values of instruments used to reduce or eliminate adverse fluctuations in cash flows of anticipated or forecasted transactions are reported in equity as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified to earnings when the related hedged items impact earnings or the anticipated transactions are no longer probable. Changes in the fair values of derivative instruments that are not designated as hedges or do not qualify for hedge accounting treatment are reported currently in earnings. Amounts reported in earnings are classified consistent with the item being hedged. The effectiveness of derivative instruments in reducing risks associated with the hedged exposures is assessed at inception and on an ongoing basis. Time value, a component of an instrument’s fair value, is excluded in assessing effectiveness for fair value hedges, except hedges of firm commitments, and included for cash flow hedges. Hedge accounting is discontinued prospectively when (i) the instrument is no longer effective in offsetting changes in fair value or cash flows of the underlying hedged item, (ii) the instrument expires, is sold, terminated or exercised, or (iii) designating the instrument as a hedge is no longer appropriate. The Company formally documents all relationships between its hedging instruments and hedged items at inception, including its risk management objective and strategy for establishing various hedge relationships. Cash flows from hedging instruments are classified in the Consolidated Statements of Cash Flows consistent with the items being hedged. Treasury Stock . Treasury stock is reported at par value. The excess of fair value over par value is first charged to paid-in capital, if any, and then to retained earnings. Research and Development . Research, development and engineering costs of $53 in 2020, $55 in 2019, and $51 in 2018 were expensed as incurred and reported in selling and administrative expense in the Consolidated Statements of Operations. Substantially all engineering and development costs are related to developing new products or designing significant improvements to existing products or processes. Costs primarily include employee salaries and benefits and facility costs. Reclassifications. Certain reclassifications of prior years’ data have been made to conform to the current year presentation. Recent Accounting and Reporting Pronouncements. Recently Adopted Accounting Standards On January 1, 2020, the Company adopted new guidance on the accounting for credit losses on financial instruments. The new guidance introduced an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. The new approach to estimating credit losses applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in operating leases and off-balance-sheet credit exposures. The guidance did not have a material impact on the Company's consolidated financial statements. On January 1, 2020, the Company adopted new guidance, on a prospective basis, which aligns the accounting for implementation costs incurred in a cloud computing arrangement that is a service arrangement (i.e. hosting arrangement) with the guidance on capitalizing costs for internal use software. The guidance did not have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Standards In December 2019, the FASB issued new guidance to simplify the accounting for income taxes by, among other things, reducing complexity in the interim-period accounting for year-to-date loss limitations and changes in tax laws. The guidance is effective for the Company on January 1, 2021. The Company is currently evaluating the impact of adopting this standard and does not expect the guidance to have a material impact on its consolidated financial statements. In March 2020, the FASB issued guidance which provides optional expedients and exceptions for applying GAAP to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and can be applied through December 31, 2022. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Cash, Cash Equivalents, and Res

Cash, Cash Equivalents, and Restricted Cash	12 Months Ended
	Dec. 31, 2020
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statement of Cash Flows were as follows: 2020 2019 Cash and cash equivalents $ 1,173 $ 607 Restricted cash included in prepaid expenses and other current assets 64 50 Restricted cash included in other non-current assets 1 6 Total restricted cash 65 56 Total cash, cash equivalents and restricted cash $ 1,238 $ 663 Amounts included in restricted cash primarily represent amounts required to be segregated by certain of the Company's receivables securitization agreements.

Receivables

Receivables	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Receivables	Receivables 2020 2019 Accounts receivable $ 1,297 $ 1,162 Less: allowance for credit losses (59) (62) Net trade receivables 1,238 1,100 Unbilled receivables 294 226 Miscellaneous receivables 251 202 $ 1,783 $ 1,528 The Company uses receivables securitization and factoring facilities in the normal course of business as part of managing its cash flows. The Company primarily accounts for transfers under these facilities as sales because it has met the criteria for control of the receivables to be considered transferred. The Company’s continuing involvement in the transfers is limited to servicing the receivables. The Company receives adequate compensation for servicing the receivables and no servicing asset or liability is recorded. As of December 31, 2020 and 2019, the Company derecognized receivables of $1,270 and $1,318 related to the facilities.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories 2020 2019 Raw materials and supplies $ 1,003 $ 905 Work in process 164 151 Finished goods 506 570 $ 1,673 $ 1,626

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2020 and 2019 were as follows: Americas Beverage European Beverage European Food Transit Packaging Other segments Total Balance at January 1, 2019 $ 842 $ 531 $ 1,291 $ 1,506 $ 272 $ 4,442 Goodwill acquired — — — 8 — 8 Goodwill impairment — — — — (25) (25) Foreign currency translation 23 3 (22) (5) 6 5 Balance at December 31, 2019 865 534 1,269 1,509 253 4,430 Foreign currency translation (26) 26 108 52 3 163 Balance at December 31, 2020 $ 839 $ 560 $ 1,377 $ 1,561 $ 256 $ 4,593 In 2019, the goodwill impairment included in other segments related to the European Aerosols and Promotional Packaging reporting unit. In recent years market demand for three-piece aerosol packaging has gradually declined. This decline combined with higher operating costs that had not been fully recovered in selling prices had an adverse impact on the expected future cash flows utilized in the Company’s valuation. As a result, the reporting unit's fair value declined below its carrying value. The carrying amount of goodwill at December 31, 2020 and 2019 was net of the following accumulated impairments: Americas Beverage European Beverage European Food Transit Packaging Other Segments Total Accumulated impairments $ 29 $ 73 $ 724 $ — $ 175 $ 1,001

Intangible Assets Intangible As

Intangible Assets Intangible Assets	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2020 December 31, 2019 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,661 $ (470) $ 1,191 $ 1,621 $ (331) $ 1,290 Trade names 565 (65) 500 541 (40) 501 Technology 165 (67) 98 158 (41) 117 Long term supply contracts 142 (55) 87 150 (48) 102 Patents 16 (12) 4 14 (9) 5 $ 2,549 $ (669) $ 1,880 $ 2,484 $ (469) $ 2,015 Amortization expense for the years ended December 31, 2020, 2019, and 201 8 was $180, $186 and $148.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment 2020 2019 Buildings and improvements $ 1,419 $ 1,402 Machinery and equipment 6,166 5,836 Land and improvements 307 298 Construction in progress 514 276 8,406 7,812 Less: accumulated depreciation and amortization (4,208) (3,925) $ 4,198 $ 3,887

Leases

Leases	12 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Leases	Leases As discussed in Note A , the Company adopted new guidance on lease accounting on January 1, 2019 on a modified retrospective basis. Total operating lease expense under the previous guidance was $50 for the year ended December 31, 2018. The components of lease expense for the years ended December 31, 2020 and 2019 were as follows: 2020 2019 Operating lease costs: Operating lease cost $ 52 $ 49 Short-term lease cost 5 4 Total operating lease costs $ 57 $ 53 Finance lease cost: Amortization of right-of-use assets $ 1 $ 1 Total finance lease costs $ 1 $ 1 Variable operating lease costs were $3 for the years ended December 31, 2020 and December 31, 2019. Interest on finance lease liabilities were less than $1 for the years ended December 31, 2020 and December 31, 2019. Supplemental cash flow information related to leases was as follows: 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 58 $ 51 Financing cash flows from finance leases 3 15 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 53 $ 33 Supplemental balance sheet information related to finance leases was as follows: 2020 2019 Finance leases: Property, plant and equipment $ 28 $ 27 Accumulated depreciation (2) (1) Property, plant and equipment, net $ 26 $ 26 Accrued liabilities $ 2 $ 2 Other non-current liabilities 10 11 Total finance lease liabilities $ 12 $ 13 The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2020 2019 Weighted average remaining lease term: Operating leases 9.3 9.5 Finance leases 6.6 7.0 Weighted average discount rate: Operating leases 4.0 % 4.2 % Finance leases 3.4 % 4.1 % Maturities of lease liabilities as of December 31, 2020 were as follows: Operating Leases Finance Leases 2021 $ 56 $ 2 2022 45 2 2023 33 2 2024 25 2 2025 20 2 Thereafter 99 3 Total lease payments 278 13 Less imputed interest (59) (1) Total $ 219 $ 12 At December 31, 2020, the Company does not have material lease commitments that have not commenced.
Leases	Leases As discussed in Note A , the Company adopted new guidance on lease accounting on January 1, 2019 on a modified retrospective basis. Total operating lease expense under the previous guidance was $50 for the year ended December 31, 2018. The components of lease expense for the years ended December 31, 2020 and 2019 were as follows: 2020 2019 Operating lease costs: Operating lease cost $ 52 $ 49 Short-term lease cost 5 4 Total operating lease costs $ 57 $ 53 Finance lease cost: Amortization of right-of-use assets $ 1 $ 1 Total finance lease costs $ 1 $ 1 Variable operating lease costs were $3 for the years ended December 31, 2020 and December 31, 2019. Interest on finance lease liabilities were less than $1 for the years ended December 31, 2020 and December 31, 2019. Supplemental cash flow information related to leases was as follows: 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 58 $ 51 Financing cash flows from finance leases 3 15 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 53 $ 33 Supplemental balance sheet information related to finance leases was as follows: 2020 2019 Finance leases: Property, plant and equipment $ 28 $ 27 Accumulated depreciation (2) (1) Property, plant and equipment, net $ 26 $ 26 Accrued liabilities $ 2 $ 2 Other non-current liabilities 10 11 Total finance lease liabilities $ 12 $ 13 The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2020 2019 Weighted average remaining lease term: Operating leases 9.3 9.5 Finance leases 6.6 7.0 Weighted average discount rate: Operating leases 4.0 % 4.2 % Finance leases 3.4 % 4.1 % Maturities of lease liabilities as of December 31, 2020 were as follows: Operating Leases Finance Leases 2021 $ 56 $ 2 2022 45 2 2023 33 2 2024 25 2 2025 20 2 Thereafter 99 3 Total lease payments 278 13 Less imputed interest (59) (1) Total $ 219 $ 12 At December 31, 2020, the Company does not have material lease commitments that have not commenced.

Other Non-Current Assets

Other Non-Current Assets	12 Months Ended
	Dec. 31, 2020
Investments, All Other Investments [Abstract]
Other Non-Current Assets	Other Non-Current Assets 2020 2019 Pension assets $ 532 $ 491 Deferred taxes 242 278 Investments 25 20 Debt issuance costs 13 15 Fair value of derivatives 11 54 Other 79 109 $ 902 $ 967

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Accrued Liabilities	Accrued Liabilities 2020 2019 Salaries and employee benefits $ 243 $ 205 Accrued taxes, other than on income 165 139 Income taxes 86 67 Accrued interest 85 82 Fair value of derivatives 29 44 Asbestos liabilities 25 25 Pension and postretirement liabilities 23 29 Restructuring 20 17 Other 497 457 $ 1,173 $ 1,065

Restructuring and Other

Restructuring and Other	12 Months Ended
	Dec. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Other	Restructuring and Other The Company recorded restructuring and other items as follows: 2020 2019 2018 Restructuring $ 23 $ 22 $ 25 Other costs / (income) 9 (41) (2) Asset impairments and sales 2 (7) (5) Transaction costs — — 26 $ 34 $ (26) $ 44 2020 Activity Restructuring costs included charges of $19 related to an internal reorganization and headcount reductions within the Transit Packaging Division. The Company continues to identify cost reduction initiatives in its businesses and it is possible that the Company may record additional restructuring charges in the future. 2019 Activity Restructuring costs included charges of $18 for termination benefits related to headcount reductions across the Company, including $14 related to for headcount reductions in the Company's European and Transit Packaging divisions. Other costs / (income) of $41 included gains of $50 arising from favorable court rulings related to the recovery of indirect taxes paid in prior years by certain of the Company's Brazilian subsidiaries and a charge of $7 related to the settlement of a litigation matter related to Signode that arose prior to its acquisition by the Company in 2018. Asset impairments and sales included gains of $13 related to asset sales partially offset by a charge of $6 related to a fire at a production facility in Asia. 2018 Activity Restructuring costs included $5 for termination benefits related to the closure of two beverage can plants in the Company's Asia Pacific segment, $12 of termination benefits related to other actions to reduce manufacturing capacity and headcount and other exit costs of $8 related to prior and current year restructuring actions. Other costs / (income) of $2 included a benefit of $6 due to the favorable settlement of a litigation matter related to Mivisa that arose prior to its acquisition by the Company in 2014. Asset impairments and sales included asset impairment charges of $13 to write down the carrying value of fixed assets related to the closure of two beverage can plants in the Company's Asia Pacific segment. Asset impairment and sales also includes gains on asset sales related to prior restructuring actions. Transaction costs related to the acquisition of Signode. Restructuring charges by segment were as follows: 2020 2019 2018 Americas Beverage $ — $ 1 $ 4 European Beverage — — 1 European Food — 4 4 Asia Pacific 1 3 5 Transit Packaging 19 6 3 Other segments 3 5 5 Corporate — 3 3 $ 23 $ 22 $ 25 Restructuring charges by type were as follows: 2020 2019 2018 Termination benefits $ 12 $ 18 $ 17 Other exit costs 11 4 8 $ 23 $ 22 $ 25

Debt

Debt	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt	Debt 2020 2019 Principal Carrying Principal Carrying outstanding amount outstanding amount Short-term debt $ 121 $ 121 $ 75 $ 75 Long-term debt Senior secured borrowings: Term loan facilities U.S. dollar at LIBOR plus 1.5% due 2024 1,029 1,023 1,100 1,094 Euro at EURIBOR plus 1.5% due 2024 1 387 387 505 504 Senior notes and debentures: €650 at 4.0% due 2022 794 791 729 725 U. S. dollar at 4.50% due 2023 1,000 997 1,000 995 €335 at 2.25% due 2023 409 407 376 372 €550 at 0.75% due 2023 671 666 617 610 €600 at 2.625% due 2024 733 729 673 668 €600 at 3.375% due 2025 733 728 673 667 U.S. dollar at 4.25% due 2026 400 396 400 395 U.S. dollar at 4.75% due 2026 875 865 875 863 U.S. dollar at 7.375% due 2026 350 348 350 348 €500 at 2.875% due 2026 610 603 561 554 U.S. dollar at 7.50% due 2096 40 40 40 40 Other indebtedness in various currencies: Fixed rate with rates in 2020 from 3.9% to 7.8% due through 2026 97 97 39 39 Variable rate with average rates in 2020 from 2.3% to 2.7% due through 2027 13 13 6 6 Total long-term debt 8,141 8,090 7,944 7,880 Less: current maturities (67) (67) (62) (62) Total long-term debt, less current maturities $ 8,074 $ 8,023 $ 7,882 $ 7,818 (1) €317 and €450 at December 31, 2020 and 2019 The estimated fair value of the Company’s long-term borrowings, using a market approach incorporating level 2 inputs such as quoted market prices for the same or similar issues, was $8,617 at December 31, 2020 and $8,410 at December 31, 2019. The revolving credit facilities include provisions for letters of credit up to $310 that reduce the amount of borrowing capacity otherwise available. At December 31, 2020, the Company’s available borrowing capacity under the credit facilities was $1,585, equal to the facilities’ aggregate capacity of $1,650 less $65 of outstanding letters of credit. The interest rate on the facilities can vary from LIBOR or EURIBOR, with a floor of zero, plus a margin of up to 1.55%, depending on the facility, based on the Company's leverage ratio. The revolving credit facilities and term loan facilities require the Company to maintain a leverage ratio of no greater than 5.00 times at December 31, 2020. The Company was in compliance with all covenants as of December 31, 2020. The weighted average interest rates were as follows: 2020 2019 2018 Short-term debt 1.9 % 2.6 % 1.0 % Revolving credit facilities 2.8 % 3.8 % 3.2 % Aggregate maturities of long-term debt, excluding unamortized discounts and debt issuance costs, for the five years subsequent to 2020 are $67, $901, $2,185, $1,966 and $743. Cash payments for interest during 2020, 2019 and 2018 were $302, $362 and $334.

Derivative and Other Financial

Derivative and Other Financial Instruments	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative and Other Financial Instruments	Derivative and Other Financial Instruments Fair Value Measurements Under U.S. GAAP a framework exists for measuring fair value, providing a three-tier hierarchy of pricing inputs used to report assets and liabilities that are adjusted to fair value. Level 1 includes inputs such as quoted prices which are available in active markets for identical assets or liabilities as of the reporting date. Level 2 includes inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 includes unobservable pricing inputs that are not corroborated by market data or other objective sources. The Company has no items valued using Level 3 inputs other than certain pension plan assets. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of assets and liabilities measured at fair value and their placement within the fair value hierarchy. The Company applies a market approach to value its commodity price hedge contracts. Prices from observable markets are used to develop the fair value of these financial instruments and they are reported under Level 2. The Company uses an income approach to value its foreign exchange forward contracts. These contracts are valued using a discounted cash flow model that calculates the present value of future cash flows under the terms of the contracts using market information as of the reporting date, such as foreign exchange spot and forward rates, and are reported under Level 2 of the fair value hierarchy. Fair value disclosures for financial assets and liabilities that were accounted for at fair value on a recurring basis are provided later in this note. In addition, see Note L for fair value disclosures related to debt. Derivative Financial Instruments In the normal course of business the Company is subject to risk from adverse fluctuations in currency exchange rates, interest rates and commodity prices. The Company manages these risks through a program that includes the use of derivative financial instruments, primarily swaps and forwards. Counterparties to these contracts are major financial institutions. The Company is exposed to credit loss in the event of nonperformance by these counterparties. The Company does not use derivative instruments for trading or speculative purposes. The Company’s objective in managing exposure to market risk is to limit the impact on earnings and cash flow. The extent to which the Company uses such instruments is dependent upon its access to these contracts in the financial markets and its success using other methods, such as netting exposures in the same currencies to mitigate foreign exchange risk and using sales agreements that permit the pass-through of commodity price and foreign exchange rate risk to customers. For derivative financial instruments accounted for in hedging relationships, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the manner in which effectiveness will be assessed. The Company formally assesses, both at inception and at least quarterly thereafter, whether the hedging relationships are effective in offsetting changes in fair value or cash flows of the related underlying exposures. When a hedge no longer qualifies for hedge accounting, the change in fair value from the date of the last effectiveness test is recognized in earnings. Any gain or loss which has accumulated in other comprehensive income at the date of the last effectiveness test is reclassified into earnings at the same time as the underlying exposure. Cash Flow Hedges The Company designates certain derivative financial instruments as cash flow hedges. No components of the hedging instruments are excluded from the assessment of hedge effectiveness. Changes in fair value of outstanding derivatives accounted for as cash flow hedges are recorded in accumulated other comprehensive income until earnings are impacted by the hedged transaction. Classification of the gain or loss in the Consolidated Statements of Operations upon release from accumulated other comprehensive income is the same as that of the underlying exposure. Contracts outstanding at December 31, 2020 mature between one When the Company discontinues hedge accounting because it is no longer probable that an anticipated transaction will occur in the originally specified period, changes to fair value accumulated in other comprehensive income are recognized immediately in earnings. The Company uses commodity forwards to hedge anticipated purchases of various commodities, including aluminum, fuel oil and natural gas. The Company also designates certain foreign exchange contracts as cash flow hedges of anticipated foreign currency denominated sales or purchases. The Company manages these risks at the operating unit level. Often, foreign currency risk is hedged together with the related commodity price risk. In June 2019, the Company entered into interest rate swaps to convert $200 of its U.S. dollar term loan facility from floating-rate to a fixed-rate of 1.82%. These interest rate swaps mature in June 2021. The following tables set forth financial information about the impact on accumulated other comprehensive income ("AOCI") and earnings from changes in fair value related to derivative instruments designated as cash flow hedges. Amount of gain / (loss) recognized in AOCI Derivatives designated as cash flow hedges 2020 2019 Foreign exchange $ — $ (8) Interest rate (1) (1) Commodities 10 (13) $ 9 $ (22) Amount of loss reclassified from AOCI into income Derivatives designated as cash flow hedges 2020 2019 Affected line item in the Foreign exchange $ (4) $ (4) Net sales Commodities 18 14 Net sales Foreign exchange (2) (1) Cost of products sold Commodities (60) (52) Cost of products sold (48) (43) Income before taxes 13 11 Provision for income taxes $ (35) $ (32) Net Income For the year ended December 31, 2021, a net gain of $35 ($28, net of tax) is expected to be reclassified to earnings. No amounts were reclassified during the years ended December 31, 2020 and 2019 in connection with anticipated transactions that were no longer considered probable. Fair Value Hedges and Contracts Not Designated as Hedges The Company designates certain derivative financial instruments as fair value hedges of recognized foreign-denominated assets and liabilities, generally trade accounts receivable and payable and unrecognized firm commitments. The notional values and maturity dates of the derivative instruments coincide with those of the hedged items. Changes in fair value of the derivative financial instruments, excluding time value, are offset by changes in fair value of the related hedged items. Certain derivative financial instruments, including foreign exchange contracts related to intercompany debt, were not designated or did not qualify for hedge accounting; however, they are effective economic hedges as the changes in their fair value, except for time value, are offset by changes from re-measurement of the related hedged items. The Company’s primary use of these derivative instruments is to offset the earnings impact that fluctuations in foreign exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. Changes in fair value of these derivative instruments are immediately recognized in earnings as foreign exchange adjustments. The impact on earnings from foreign exchange contracts designated as fair value hedges was a gain of $27 for the year ended December 31, 2020 and a gain of $1 for the year ended December 31, 2019. These adjustments were reported within foreign exchange in the Consolidated Statements of Operations and were offset by changes in the fair values of the related hedged items. The following table sets forth the impact on earnings from derivatives not designated as hedges. Pre-tax amount of gain / (loss) recognized in earnings Derivatives not designated as hedges 2020 2019 Affected line item in the Statement of Operations Foreign exchange $ — $ (3) Net sales Foreign exchange — 3 Cost of products sold Foreign exchange 30 (26) Foreign exchange $ 30 $ (26) Net Investment Hedges The Company designates certain debt and derivative instruments as net investment hedges to manage foreign currency risk relating to net investments in subsidiaries denominated in foreign currencies. For the years ended December 31, 2020 and 2019, the Company recorded a loss of $1 ($1, net of tax) and a gain of $27 ($27, net of tax) in other comprehensive income for certain debt instruments that are designated as hedges of its net investment in a euro-based subsidiary. As of December 31, 2020, cumulative losses of $33 ($10, net of tax) were recognized in accumulated other comprehensive income related to these net investment hedges and the carrying amount of the hedged net investment was approximately €1,113 ($1,359) at December 31, 2020. In November 2018, the Company entered into a series of cross-currency swaps with an aggregate notional value of $875. The swaps are designated as hedges of the Company's net investment in a euro-based subsidiary. Under the cross-currency contracts, the Company will receive semi-annual fixed U.S. dollar payments at a rate of 4.75% of the U.S. notional value and pay 1.84% on the euro notional value. In May 2019, the Company entered into a cross-currency swap with an aggregate notional value of $200. The swap is designated as a hedge of the Company's net investment in a euro-based subsidiary. Under the cross-currency contract, the Company receives quarterly variable U.S. dollar payments at a rate of LIBOR plus a floating rate spread on the dollar notional value and pays EURIBOR plus a floating rate spread on the euro notional value. Gains or losses on net investment hedges remain in accumulated other comprehensive income until disposal of the underlying assets. The following tables set forth financial information about the impact on accumulated other comprehensive income from changes in the fair value of derivative instruments designated as net investment hedges. Amount of (loss) / gain recognized in AOCI Derivatives designated as net investment hedges 2020 2019 Foreign exchange $ (48) $ 26 Gains and losses representing components excluded from the assessment of effectiveness on derivatives designated as net investment hedges are recognized in accumulated other comprehensive income. Fair Values of Derivative Financial Instruments The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis. Balance Sheet classification December 31, December 31, 2019 Balance Sheet classification December 31, December 31, 2019 Derivatives designated as hedging instruments Foreign exchange contracts cash flow Other current assets $ 9 $ 10 Accrued liabilities $ 8 $ 15 Other non-current assets — 1 Other non-current liabilities 1 1 Foreign exchange contracts fair value Other current assets 2 1 Accrued liabilities 6 3 Commodities contracts cash flow Other current assets 45 11 Accrued liabilities 11 21 Other non-current assets 4 — Other non-current liabilities — — Interest rate contracts cash flow Other non-current assets — — Other non-current liabilities 2 1 Net investment hedge Other non-current assets 7 51 Other non-current liabilities 20 2 $ 67 $ 74 $ 48 $ 43 Derivatives not designated as hedging instruments Foreign exchange contracts Other current assets $ 9 $ 7 Accrued liabilities $ 4 $ 5 Other non-current assets — 2 Other non-current liabilities — 1 $ 9 $ 9 $ 4 $ 6 Total derivatives $ 76 $ 83 $ 52 $ 49 Fair Value Hedge Carrying Amounts Carrying amount of the hedged assets and liabilities Line item in the Balance Sheet in which the hedged item is included December 31, 2020 December 31, 2019 Receivables, net 11 12 Accrued liabilities 100 83 As of December 31, 2020 and 2019, the cumulative amounts of fair value hedging adjustments included in the carrying amount of the hedged assets and liabilities were net gains of $4 and $2. Offsetting of Derivative Assets and Liabilities Certain derivative financial instruments are subject to agreements with counterparties similar to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments. In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2020 Derivative assets $ 76 $ 11 $ 65 Derivative liabilities 52 11 41 Balance at December 31, 2019 Derivative assets $ 83 $ 16 $ 67 Derivative liabilities 49 16 33 Notional Values of Outstanding Derivative Instruments The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets were: December 31, 2020 December 31, 2019 Derivatives designated as cash flow hedges: Foreign exchange $ 1,127 $ 1,030 Commodities 248 334 Interest rate 200 200 Derivatives designated as fair value hedges: Foreign exchange 183 142 Derivatives designated as net investment hedges: Foreign exchange 1,075 1,075 Derivatives not designated as hedges: Foreign exchange 722 1,017

Asbestos-Related Liabilities

Asbestos-Related Liabilities	12 Months Ended
	Dec. 31, 2020
Liability for Asbestos and Environmental Claims [Abstract]
Asbestos-Related Liabilities	Asbestos-Related Liabilities Crown Cork & Seal Company, Inc. (“Crown Cork”) is one of many defendants in a substantial number of lawsuits filed throughout the United States by persons alleging bodily injury as a result of exposure to asbestos. These claims arose from the insulation operations of a U.S. company, the majority of whose stock Crown Cork purchased in 1963. Approximately ninety days after the stock purchase, this U.S. company sold its insulation assets and was later merged into Crown Cork. Prior to 1998, amounts paid to asbestos claimants were covered by a fund made available to Crown Cork under a 1985 settlement with carriers insuring Crown Cork through 1976, when Crown Cork became self-insured. The fund was depleted in 1998 and the Company has no remaining coverage for asbestos-related costs. The states of Alabama, Arizona, Arkansas, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Michigan, Mississippi, Nebraska, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, West Virginia, Wisconsin and Wyoming enacted legislation that limits asbestos-related liabilities under state law of companies such as Crown Cork that allegedly incurred these liabilities because they are successors by corporate merger to companies that had been involved with asbestos. The legislation, which applies to future and, with the exception of Arkansas, Georgia, South Carolina, South Dakota, West Virginia and Wyoming, pending claims at the time of enactment, caps asbestos-related liabilities at the fair market value of the predecessor's total gross assets adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the total value of its predecessor's assets adjusted for inflation. Crown Cork has integrated the legislation into its claims defense strategy. The Company cautions, however, that the legislation may be challenged and there can be no assurance regarding the ultimate effect of the legislation on Crown Cork. In June 2003, the State of Texas enacted legislation that limits the asbestos-related liabilities in Texas courts of companies such as Crown Cork that allegedly incurred these liabilities because they are successors by corporate merger to companies that had been involved with asbestos. The Texas legislation, which applies to future and pending claims, caps asbestos-related liabilities at the total gross value of the predecessor’s assets adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the total adjusted value of its predecessor’s assets. In October 2010, the Texas Supreme Court reversed a lower court decision, Barbara Robinson v. Crown Cork & Seal Company, Inc., No. 14-04-00658-CV, Fourteenth Court of Appeals, Texas, which had upheld the dismissal of an asbestos-related case against Crown Cork. The Texas Supreme Court held that the Texas legislation was unconstitutional under the Texas Constitution when applied to asbestos-related claims pending against Crown Cork when the legislation was enacted in June of 2003. The Company believes that the decision of the Texas Supreme Court is limited to retroactive application of the Texas legislation to asbestos-related cases that were pending against Crown Cork in Texas on June 11, 2003 and therefore, in its accrual, continues to assign no value to claims filed after June 11, 2003. In December 2001, the Commonwealth of Pennsylvania enacted legislation that limits the asbestos-related liabilities of Pennsylvania corporations that are successors by corporate merger to companies involved with asbestos. The legislation limits the successor’s liability for asbestos to the acquired company’s asset value adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the acquired company’s adjusted asset value. In November 2004, the legislation was amended to address a Pennsylvania Supreme Court decision (Ieropoli v. AC&S Corporation, et. al., No. 117 EM 2002) which held that the statute violated the Pennsylvania Constitution due to retroactive application. The Company cautions that the limitations of the statute, as amended, are subject to litigation and may not be upheld. The Company further cautions that an adverse ruling in any litigation relating to the constitutionality or applicability to Crown Cork of one or more statutes that limits the asbestos-related liability of alleged defendants like Crown Cork could have a material impact on the Company. The Company's approximate claims activity for the years ended 2020, 2019 and 2018 was as follows: 2020 2019 2018 Beginning claims 56,000 56,000 55,500 New claims 1,500 2,000 2,000 Settlements or dismissals (1,500) (2,000) (1,500) Ending claims 56,000 56,000 56,000 For the years ended December 31, 2020, 2019, and 2018, the Company made cash payments of $21, $22, and $21 to settle asbestos claims and pay related legal and defense costs. In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes by year of exposure and state filed. As of December 31, 2020 and December 31, 2019, the Company's outstanding claims were: 2020 2019 Claimants alleging first exposure after 1964 16,500 16,500 Claimants alleging first exposure before or during 1964 filed in: Texas 13,000 13,000 Pennsylvania 1,500 1,500 Other states that have enacted asbestos legislation 6,000 6,000 Other states 19,000 19,000 Total claims outstanding 56,000 56,000 The outstanding claims in each period exclude approximately 19,000 inactive claims. Due to the passage of time, the Company considers it unlikely that the plaintiffs in these cases will pursue further action against the Company. The exclusion of these inactive claims had no effect on the calculation of the Company’s accrual as the claims were filed in states, as described above, where the Company’s liability is limited by statute. With respect to claimants alleging first exposure to asbestos before or during 1964, the Company does not include in its accrual any amounts for settlements in states where the Company’s liability is limited by statute except for certain pending claims in Texas as described earlier. With respect to post-1964 claims, regardless of the existence of asbestos legislation, the Company does not include in its accrual any amounts for settlement of these claims because of increased difficulty of establishing identification of relevant insulation products as the cause of injury. Given its settlement experience with post-1964 claims, the Company does not believe that an adverse ruling in the Texas or Pennsylvania asbestos litigation cases, or in any other state that has enacted asbestos legislation, would have a material impact on the Company with respect to such claims. As of December 31, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows: 2020 2019 2018 Total claims 23 % 22 % 22 % Pre-1964 claims in states without asbestos legislation 41 % 41 % 41 % Crown Cork has entered into arrangements with plaintiffs’ counsel in certain jurisdictions with respect to claims which are not yet filed, or asserted, against it. However, Crown Cork expects claims under these arrangements to be filed or asserted against Crown Cork in the future. The projected value of these claims is included in the Company’s estimated liability as of December 31, 2020. Approximately 81% of the claims outstanding at the end of 2020 were filed by plaintiffs who do not claim a specific amount of damages or claim a minimum amount as established by court rules relating to jurisdiction; approximately 16% were filed by plaintiffs who claim damages of less than $5; approximately 3% were filed by plaintiffs who claim damages from $5 to less than $100 (36% of whom claim damages less than $25) and 14 claims were filed by plaintiffs who claim damages in excess of $100. As of December 31, 2020, the Company’s accrual for pending and future asbestos-related claims and related legal costs was $251, including $214 for unasserted claims. The Company determines its accrual without limitation to a specified time period. It is reasonably possible that the actual loss could be in excess of the Company’s accrual. However, the Company is unable to estimate the reasonably possible loss in excess of its accrual due to uncertainty in the following assumptions that underlie the Company’s accrual and the possibility of losses in excess of such accrual: the amount of damages sought by the claimant, the Company and claimant’s willingness to negotiate a settlement, the terms of settlements of other defendants with asbestos-related liabilities, the bankruptcy filings of other defendants (which may result in additional claims and higher settlements for non-bankrupt defendants), the nature of pending and future claims (including the seriousness of alleged disease, whether claimants allege first exposure to asbestos before or during 1964 and the claimant’s ability to demonstrate the alleged link to Crown Cork), the volatility of the litigation environment, the defense strategies available to the Company, the level of future claims, the rate of receipt of claims, the jurisdiction in which claims are filed, and the effect of state asbestos legislation (including the validity and applicability of the Pennsylvania legislation to non-Pennsylvania jurisdictions, where the substantial majority of the Company’s asbestos cases are filed).

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	Commitments and Contingent Liabilities The Company, along with others in most cases, has been identified by the EPA or a comparable state environmental agency as a Potentially Responsible Party (“PRP”) at a number of sites and has recorded aggregate accruals of $8 for its share of estimated future remediation costs at these sites. The Company has been identified as having either directly or indirectly disposed of commercial or industrial waste at the sites subject to the accrual, and where appropriate and supported by available information, generally has agreed to be responsible for a percentage of future remediation costs based on an estimated volume of materials disposed in proportion to the total materials disposed at each site. The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites. The Company has also recorded aggregate accruals of $7 for remediation activities at various worldwide locations that are owned by the Company and for which the Company is not a member of a PRP group. Although the Company believes its accruals are adequate to cover its portion of future remediation costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flow. Any possible loss or range of potential loss that may be incurred in excess of the recorded accruals cannot be estimated. In March 2015, the Bundeskartellamt, or German Federal Cartel Office (“FCO”), conducted unannounced inspections of the premises of several metal packaging manufacturers, including a German subsidiary of the Company. The local court order authorizing the inspection cited FCO suspicions of anti-competitive agreements in the German market for the supply of metal packaging products. The Company conducted an internal investigation into the matter and discovered instances of inappropriate conduct by certain employees of German subsidiaries of the Company. The Company cooperated with the FCO and submitted a leniency application with the FCO which disclosed the findings of its internal investigation to date. In April 2018, the FCO discontinued its national investigation and referred the matter to the European Commission (the “Commission”). Following the referral, Commission officials conducted unannounced inspections of the premises of several metal packaging manufacturers, including Company subsidiaries in Germany, France and the United Kingdom. The Commission's investigation is ongoing and, to date, the Commission has not officially charged the Company or any of its subsidiaries with violations of competition law. The Company is cooperating with the Commission and submitted a leniency application with the Commission with respect to the findings of the investigation in Germany referenced above. This application may lead to the reduction of possible future penalties. At this stage of the investigation the Company believes that a loss is probable but is unable to predict the ultimate outcome of the Commission’s investigation and is unable to estimate the loss or possible range of losses that could be incurred, and has therefore not recorded a charge in connection with the actions by the Commission. If the Commission finds that the Company or any of its subsidiaries violated competition law, fines levied by the Commission could be material to the Company's operating results and cash flows for the periods in which they are resolved or become reasonably estimable. In March 2017, U.S. Customs and Border Protection (“CBP”) at the Port of Milwaukee issued a penalty notification alleging that certain of the Company’s subsidiaries intentionally misclassified the importation of certain goods into the U.S. during the period 2004-2009. CBP initially assessed a penalty of $18 and subsequently mitigated to $6. The Company has acknowledged to CBP that the goods were misclassified and has paid all related duties. The Company has asserted that the misclassification was unintentional and disputes the penalty assessment. At the present time, based on the information available, the Company does not believe that a loss for the alleged intentional misclassification is probable. There can be no assurance the Company will be successful in contesting the assessed penalty. The Company and its subsidiaries are also subject to various other lawsuits and claims with respect to labor, environmental, securities, vendor and other matters arising out of the Company’s normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes that the ultimate liabilities resulting from such lawsuits and claims will not materially affect the Company’s consolidated earnings, financial position or cash flow. The Company has various commitments to purchase materials, supplies and utilities as part of the ordinary conduct of business. The Company’s basic raw materials for its products are steel and aluminum, both of which are purchased from multiple sources. The Company is subject to fluctuations in the cost of these raw materials and has periodically adjusted its selling prices to reflect these movements. There can be no assurance, however, that the Company will be able to fully recover any increases or fluctuations in raw material costs from its customers. The Company also has commitments for standby letters of credit and for purchases of capital assets.

Other Non-Current Liabilities

Other Non-Current Liabilities	12 Months Ended
	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Other Non-Current Liabilities	Other Non-Current Liabilities 2020 2019 Deferred taxes $ 393 $ 405 Asbestos liabilities 226 248 Postemployment benefits 37 36 Income taxes payable 28 25 Fair value of derivatives 23 5 Environmental 12 12 Finance lease liabilities 10 11 Other 127 115 $ 856 $ 857 Income taxes payable includes unrecognized tax benefits as discussed in Note R .

Pension and Other Postretiremen

Pension and Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2020
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits Pensions. The Company sponsors various pension plans covering certain U.S. and non-U.S. employees, and participates in certain multi-employer pension plans. The benefits under the Company plans are based primarily on years of service and either the employees’ remuneration near retirement or a fixed dollar multiple. A measurement date of December 31 was used for all plans presented below. The components of pension expense were as follows: U.S. Plans 2020 2019 2018 Service cost $ 18 $ 15 $ 17 Interest cost 38 50 47 Expected return on plan assets (73) (70) (85) Settlements 3 — — Amortization of actuarial loss 56 55 51 Amortization of prior service cost 1 1 1 Net periodic cost $ 43 $ 51 $ 31 Non-U.S. Plans 2020 2019 2018 Service cost $ 12 $ 15 $ 26 Interest cost 53 71 75 Expected return on plan assets (107) (138) (159) Settlements 63 44 38 Curtailments — (14) — Amortization of actuarial loss 28 38 45 Amortization of prior service credit — (1) (11) Net periodic cost $ 49 $ 15 $ 14 The settlement charges in each year arose from the payment of lump sum buy-outs to settle certain pension obligations using plan assets. The Company may incur additional settlement charges in 2021. The curtailment gain in 2019 was to recognize prior service credits that were previously recorded in accumulated other comprehensive income in connection with the closure of a non-U.S. defined benefit pension plan. Additional pension expense of $6 in 2020 and $5 in each of 2019 and 2018 was recognized for multi-employer plans. The projected benefit obligations, accumulated benefit obligations, plan assets and funded status of the Company's U.S. and non-U.S. plans were as follows: U.S. Plans Non-U.S. Plans 2020 2019 2020 2019 Projected Benefit Obligations Benefit obligations at January 1 $ 1,440 $ 1,371 $ 3,220 $ 3,102 Service cost 18 15 12 15 Interest cost 38 50 53 71 Plan participants’ contributions — — 2 2 Amendments 1 (1) — — Settlements (7) — (271) (152) Curtailments — — — (18) Actuarial loss 109 133 278 242 Benefits paid (94) (128) (151) (152) Foreign currency translation — — 102 110 Benefit obligations at December 31 $ 1,505 $ 1,440 $ 3,245 $ 3,220 Plan Assets Fair value of plan assets at January 1 $ 1,131 $ 1,012 $ 3,480 $ 3,264 Actual return on plan assets 113 244 334 373 Employer contributions 9 3 18 19 Plan participants’ contributions — — 2 2 Settlements (7) — (271) (152) Acquisitions — — — — Benefits paid (94) (128) (152) (152) Foreign currency translation — — 107 126 Fair value of plan assets at December 31 $ 1,152 $ 1,131 $ 3,518 $ 3,480 Funded status $ (353) $ (309) $ 273 $ 260 Accumulated benefit obligations at December 31 $ 1,445 $ 1,397 $ 3,177 $ 3,182 For the year ended December 31, 2020, actuarial losses for the Company’s U.S. and non-U.S. pension plans totaled $387. Actuarial gains and losses arise each year primarily due to changes in discount rates, differences in actual plan asset returns compared to expected returns, and changes in actuarial assumptions such as mortality. The loss in 2020 is primarily due to lower discount rates at the end of 2020 compared to 2019, partially offset by a gain of $268 primarily due to actual asset returns higher than expected returns. U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2020 2019 Projected benefit obligations $ 1,505 $ 1,440 Accumulated benefit obligations 1,445 1,397 Fair value of plan assets 1,152 1,131 Non-U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2020 2019 Projected benefit obligations $ 428 $ 399 Accumulated benefit obligations 386 383 Fair value of plan assets 191 187 Non-U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2020 2019 Projected benefit obligations $ 432 $ 403 Accumulated benefit obligations 389 386 Fair value of plan assets 194 189 The Company’s investment strategy in its U.S. plan is designed to generate returns that are consistent with providing benefits to plan participants within the risk tolerance of the plan. Asset allocation is the primary determinant of return levels and investment risk exposure. The assets of the plan are broadly diversified in terms of securities and security types in order to limit the potential of large losses from any one security. The strategic ranges for asset allocation in the U.S. plans are as follows: U.S. equities 39 % to 49 % International equities 12 % to 18 % Fixed income 16 % to 26 % Balanced funds 7 % to 13 % Real estate 7 % to 13 % The Company’s investment strategy in its U.K. plan, the largest non-U.S. plan, is designed to achieve a funding level of 100% within the next 6 years. The Company seeks to achieve this objective with a risk level commensurate with a 5% chance of the funding level falling between 4% and 7% in any one year. The strategic ranges for asset allocation in the U.K. plan are as follows: Investment grade credit 30 % to 100 % Equities 0 % to 30 % Hedge funds 0 % to 10 % Real estate 0 % to 5 % Alternative credit 0 % to 15 % Other 0 % to 20 % Pension assets are classified into three levels. Level 1 asset values are derived from quoted prices which are available in active markets as of the report date. Level 2 asset values are derived from other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the report date. Level 3 asset values are derived from unobservable pricing inputs that are not corroborated by market data or other objective sources. Level 1 Investments Equity securities are valued at the latest quoted prices taken from the primary exchange on which the security trades. Mutual funds are valued at the net asset value (NAV) of shares held at year-end. Level 2 Investments Fixed income securities, including government issued debt, corporate debt, asset-backed and structured debt securities are valued using the latest bid prices or valuations based on a matrix system (which considers such factors as benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and other reference data including market research publications). Derivatives, which consist mainly of interest rate swaps, are valued using a discounted cash flow pricing model based on observable market data. Level 3 Investments Hedge funds and private equity funds are valued at the NAV at year-end. The values assigned to private equity funds are based upon assessments of each underlying investment, incorporating valuations that consider the evaluation of financing and sale transactions with third parties, expected cash flows and market-based information, including comparable transactions, and performance multiples among other factors. Real estate investments are based on third party appraisals. Investments Measured Using NAV per Share Practical Expedient Investments measured using NAV per share as a practical expedient include investment funds that invest in global equity, emerging markets and fixed income. The global equity funds invest in equity securities of various market sectors including industrial materials, consumer discretionary goods and services, financial infrastructure, technology, and health care. The emerging markets funds invest in equity markets within financial services, consumer goods and services, energy, and technology. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair value. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in different fair value measurements at the reporting date. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and their placement within the fair value hierarchy. The levels assigned to the defined benefit plan assets as of December 31, 2020 and 2019 are summarized in the tables below: 2020 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 157 $ 498 $ 655 Global large cap equity — 9 9 U.S. large cap equity 178 4 182 U.S. mid/small cap equity 301 22 323 Mutual funds – global equity 88 — 88 Mutual funds – U.S. equity 56 — 56 Mutual funds – fixed income 75 — 75 855 533 1,388 Level 2 Government issued debt securities — 298 $ 298 Corporate debt securities 58 647 705 Asset backed securities — 2 2 Structured debt — 1,034 1,034 Insurance contracts — 115 115 Derivatives — 166 166 Investment funds – fixed income — 128 128 Investment funds – global equity — 69 69 58 2,459 2,517 Level 3 Investment funds – real estate 91 181 272 Hedge funds — 2 2 Private equity 5 46 51 Real estate – direct 23 12 35 119 241 360 Total assets in fair value hierarchy 1,032 3,233 4,265 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 112 25 137 Investment funds – global equity — 141 141 Investment funds – emerging markets 7 — 7 Hedge funds — 109 109 119 275 394 Total investments at fair value $ 1,151 $ 3,508 $ 4,659 2019 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 23 $ 190 $ 213 Global large cap equity — 7 7 U.S. large cap equity 155 4 159 U.S. mid/small cap equity 218 27 245 Mutual funds – global equity 144 — 144 Mutual funds – U.S. equity 206 — 206 Mutual funds – fixed income 67 — 67 813 228 1,041 Level 2 Government issued debt securities — 260 $ 260 Corporate debt securities 52 332 384 Asset backed securities — 2 2 Structured debt — 811 811 Insurance contracts — 105 105 Derivatives — 194 194 Investment funds – fixed income — 373 373 Investment funds – global equity — 297 297 Investment funds – emerging markets — 33 33 52 2,407 2,459 Level 3 Investment funds – real estate 96 220 316 Hedge funds — 43 43 Private equity 5 70 75 Real estate – direct 21 9 30 122 342 464 Total assets in fair value hierarchy 987 2,977 3,964 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 102 91 193 Investment funds – global equity 18 78 96 Investment funds – emerging markets 23 — 23 Hedge funds — 328 328 143 497 640 Total investments at fair value $ 1,130 $ 3,474 $ 4,604 (a) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Accrued income excluded from the tables above was as follows: 2020 2019 U.S. plan assets $ 1 $ 1 Non-U.S. plan assets 10 6 Plan assets include $323 and $244 of the Company’s common stock at December 31, 2020 and 2019. The following tables reconcile the beginning and ending balances of plan assets measured using significant unobservable inputs (Level 3). Hedge Private Real Total Balance at January 1, 2019 $ 113 $ 103 $ 317 $ 533 Foreign currency translation 4 4 8 16 Asset returns – assets held at reporting date (6) (22) 25 (3) Asset returns – assets sold during the period 7 17 6 30 Purchases, sales and settlements, net (75) (27) (10) (112) Balance at December 31, 2019 43 75 346 464 Foreign currency translation 1 2 7 10 Asset returns – assets held at reporting date 3 6 (15) (6) Asset returns – assets sold during the period (12) (9) 3 (18) Purchases, sales and settlements, net (33) (23) (34) (90) Balance at December 31, 2020 $ 2 $ 51 $ 307 $ 360 The following table presents additional information about the pension plan assets valued using net asset value as a practical expedient: Fair Value Redemption Frequency Redemption Notice Period Balance at December 31, 2020 Investment funds – fixed income $ 137 Semi-monthly 1- 5 days Investment funds – global equity 141 Monthly 1 - 15 days Investment funds – emerging markets 7 Daily 30 days Hedge funds 109 Monthly 1 - 30 days Balance at December 31, 2019 Investment funds – fixed income $ 193 Semi-monthly 1- 5 days Investment funds – global equity 96 Monthly 1 - 15 days Investment funds – emerging markets 23 Daily 30 days Hedge funds 328 Monthly 1 - 30 days The pension plan assets valued using net asset value as a practical expedient do not have any unfunded commitments. Pension assets and liabilities included in the Consolidated Balance Sheets were: 2020 2019 Non-current assets $ 532 $ 491 Current liabilities 8 13 Non-current liabilities 610 533 The Company’s current liability at December 31, 2020, represents the expected required payments to be made for unfunded plans over the next twelve months. Total estimated 2021 employer contributions are $22 for the Company’s pension plans. Changes in the net loss and prior service cost (credit) for the Company’s pension plans were: 2020 2019 2018 Net loss Prior Net loss Prior Net loss Prior Balance at January 1 $ 1,808 $ 8 $ 1,962 $ (6) $ 2,057 $ (16) Reclassification to net periodic benefit cost (150) (1) (137) 14 (134) 10 Current year gain / (loss) 118 — (53) — 103 — Amendments — 1 — — — — Foreign currency translation 26 — 36 — (64) — Balance at December 31 $ 1,802 $ 8 $ 1,808 $ 8 $ 1,962 $ (6) Expected future benefit payments as of December 31, 2020 are: U.S. Non-U.S. 2021 $ 95 $ 166 2022 97 161 2023 100 159 2024 98 159 2025 93 159 2026 - 2030 429 777 The weighted average actuarial assumptions used to calculate the benefit obligations at December 31 were: U.S. Plans 2020 2019 2018 Discount rate 2.5 % 3.2 % 4.3 % Compensation increase 4.7 % 4.7 % 4.5 % Non-U.S. Plans 2020 2019 2018 Discount rate 1.4 % 2.1 % 2.9 % Compensation increase 3.0 % 3.0 % 3.2 % The weighted average actuarial assumptions used to calculate pension expense for each year were: U.S. Plans 2020 2019 2018 Discount rate - service cost 3.6 % 4.7 % 3.9 % Discount rate - interest cost 2.8 % 3.9 % 3.2 % Compensation increase 4.7 % 4.5 % 4.7 % Long-term rate of return 6.8 % 7.3 % 7.3 % Non-U.S. Plans 2020 2019 2018 Discount rate - service cost 2.6 % 3.0 % 2.6 % Discount rate - interest cost 1.9 % 2.7 % 2.2 % Compensation increase 3.0 % 3.2 % 3.2 % Long-term rate of return 3.3 % 4.3 % 4.4 % The expected long-term rate of return on plan assets is determined by taking into consideration expected long-term returns associated with each major asset class based on long-term historical ranges, inflation assumptions and the expected net value from active management of the assets based on actual results. Other Postretirement Benefit Plans. The Company sponsors unfunded plans to provide health care and life insurance benefits to certain pensioners and survivors. Generally, the medical plans pay a stated percentage of medical expenses reduced by deductibles and other coverages. Life insurance benefits are generally provided by insurance contracts. The Company reserves the right, subject to existing agreements, to change, modify or discontinue the plans. A measurement date of December 31 was used for the plans presented below. The components of net postretirement benefits cost were as follows: Other Postretirement Benefits 2020 2019 2018 Service cost $ 1 $ 1 $ 4 Interest cost 5 6 6 Amortization of prior service credit (26) (34) (37) Amortization of actuarial loss 4 3 4 Net periodic benefit credit $ (16) $ (24) $ (23) Changes in the benefit obligations were: 2020 2019 Benefit obligations at January 1 $ 164 $ 147 Service cost 1 1 Interest cost 5 6 Amendments — 6 Actuarial loss 7 14 Benefits paid (11) (13) Foreign currency translation — 3 Benefit obligations at December 31 $ 166 $ 164 Changes in the net loss and prior service credit for the Company’s postretirement benefit plans were: 2020 2019 2018 Net Prior Net Prior Net Prior Balance at January 1 $ 42 $ (72) $ 31 $ (105) $ 49 $ (142) Reclassification to net periodic benefit cost (4) 26 (3) 34 (4) 37 Current year gain / (loss) 7 — 14 — (14) — Amendments — — — (1) — — Balance at December 31 $ 45 $ (46) $ 42 $ (72) $ 31 $ (105) Expected future benefit payments are as follows: Benefit Payments 2021 $ 15 2022 13 2023 12 2024 12 2025 11 2026 - 2030 48 The assumed health care cost trend rates at December 31, 2020 were as follows: Health care cost trend rate assumed for 2020 5.2 % Rate that the cost trend rate gradually declines to 4.0 % Year that the rate reaches the rate it is assumed to remain 2035 Weighted average discount rates used to calculate the benefit obligations at the end of each year and the cost for each year are presented below. 2020 2019 2018 Benefit obligations 2.8 % 3.5 % 4.5 % Service cost 4.1 % 4.8 % 4.9 % Interest cost 3.3 % 4.2 % 4.1 %

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of income before income taxes were as follows: 2020 2019 2018 U.S. $ 93 $ (3) $ 21 Foreign 833 789 719 $ 926 $ 786 $ 740 The provision for income taxes consisted of the following: 2020 2019 2018 Current tax: U.S. federal $ — $ (1) $ (2) State and foreign 211 202 183 $ 211 $ 201 $ 181 Deferred tax: U.S. federal $ 37 $ 16 $ 31 State and foreign (4) (51) 4 33 (35) 35 Total $ 244 $ 166 $ 216 The provision for income taxes differs from the amount of income tax determined by applying the U.S. statutory federal income tax rate to pre-tax income as a result of the following items: 2020 2019 2018 U.S. statutory rate at 21% $ 194 $ 166 $ 155 Tax on foreign income 30 7 30 U.S. taxes on foreign income, net of credits 14 15 24 Valuation allowance changes (11) (33) (1) Tax contingencies 1 19 (2) Tax law changes 4 (11) 4 Other items, net 12 3 6 Income tax provision $ 244 $ 166 $ 216 The Company benefits from certain incentives in Brazil which allow it to pay reduced income taxes. The incentives expire at various dates beginning in December 2025. These incentives increased net income attributable to the Company by $17 in both 2020 and 2019 and $14 in 2018. The Company paid taxes of $189, $173 and $177 in 2020, 2019 and 2018. In 2019, the Company recorded an income tax benefit of $36 related to a deferred tax valuation allowance release resulting from an internal reorganization. Additionally, the Company recorded a charge of $15 related to the settlement of a pre-acquisition tax contingency that arose from a transaction that occurred prior to its acquisition of Signode in 2018. The Company also recorded a benefit of $9 arising from tax law changes in India. In 2018, the Company recorded a charge of $24 related to local taxes on the distributions of foreign earnings, which were previously asserted to be indefinitely reinvested. As of December 31, 2020 the Company has not provided deferred taxes on approximately $1,500 of earnings in certain non-U.S. subsidiaries because such earnings are indefinitely reinvested in its international operations. Upon distribution of such earnings in the form of dividends or otherwise, the Company may be subject to incremental foreign tax. It is not practicable to estimate the amount of foreign tax that might be payable. The components of deferred taxes at December 31 were: 2020 2019 Assets Liabilities Assets Liabilities Tax carryforwards $ 433 $ — $ 512 $ — Postretirement and postemployment benefits 39 — 40 — Pensions 139 101 176 124 Property, plant and equipment 29 172 23 174 Intangible assets — 385 — 401 Asbestos 61 — 66 — Accruals and other 102 92 88 90 Right of use assets — 42 — 30 Lease liabilities 43 — 30 — Valuation allowances (205) — (243) — Total $ 641 $ 792 $ 692 $ 819 Tax carryforwards expire as follows: Year Amount 2021 $ 20 2022 75 2023 12 2024 13 2025 27 Thereafter 141 Unlimited 145 Tax carryforwards expiring in 2022 include $63 of U.S. federal foreign tax credits which, based on current projections, the Company believes it will utilize before expiration. Tax carryforwards expiring after 2025 include $115 of U.S. state tax loss carryforwards. The unlimited category includes $39 of Luxembourg tax loss carryforwards and $69 of French tax loss carryforwards. Realization of any portion of the Company’s deferred tax assets is dependent upon the availability of taxable income in the relevant jurisdictions. The Company considers all sources of taxable income, including (i) taxable income in any available carry back period, (ii) the reversal of taxable temporary differences, (iii) tax-planning strategies, and (iv) taxable income expected to be generated in the future other than from reversing temporary differences. The Company also considers whether there have been cumulative losses in recent years. The Company records a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company’s valuation allowances at December 31, 2020 includes $171 primarily related to the portion of U.S. state tax loss carryforwards that the Company does not believe are more likely than not to be utilized prior to their expiration. The Company’s ability to utilize state tax loss carryforwards is impacted by several factors including taxable income, expiration dates, limitations imposed by certain states on the amount of loss carryforwards that can be used in a given year to offset taxable income and whether the state permits the Company to file a combined return. Management’s estimate of the appropriate valuation allowance in any jurisdiction involves a number of assumptions and judgments, including the amount and timing of future taxable income. Should future results differ from management’s estimates, it is possible there could be future adjustments to the valuation allowances that would result in an increase or decrease in tax expense in the period such changes in estimates are made. A reconciliation of unrecognized tax benefits follows: 2020 2019 2018 Balance at January 1 $ 41 $ 37 $ 29 Additions related to acquisitions — — 13 Additions for prior year tax positions 1 20 1 Lapse of statute of limitations — (1) (3) Settlements — (15) (2) Foreign currency translation 2 — (1) Balance at December 31 $ 44 $ 41 $ 37 The Company’s unrecognized tax benefits include potential liabilities related to transfer pricing, foreign withholding taxes, and non-deductibility of expenses and exclude $2 of interest and penalties as of December 31, 2020. The total interest and penalties recorded in income tax expense was less than $1 in 2020, 2019 and 2018. As of December 31, 2020, unrecognized tax benefits of $44, if recognized, would affect the Company's effective tax rate. The Company’s unrecognized tax benefits are not expected to increase over the next twelve months and are expected to decrease as open tax years lapse or claims are settled. The Company is unable to estimate a range of reasonably possible changes in its unrecognized tax benefits in the next twelve months as it is unable to predict when, or if, the tax authorities will commence their audits, the time needed for the audits, and the audit findings that will require settlement with the applicable tax authorities, if any.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Capital Stock	Capital Stock A summary of common share activity for the years ended December 31 follows (in shares): 2020 2019 2018 Common shares outstanding at January 1 135,577,878 135,173,948 134,275,609 Shares repurchased (1,240,328) (106,388) (92,167) Shares issued upon exercise of employee stock options — 70,000 — Restricted stock issued to employees, net of forfeitures 439,700 416,695 958,672 Shares issued to non-employee directors 23,780 23,623 31,834 Common shares outstanding at December 31 134,801,030 135,577,878 135,173,948 In 2021, the Company announced plans to initiate a regularly quarterly dividend beginning in the first quarter of 2021. On February 25, 2021, the Company's Board of Directors declared a dividend of $0.20 per share payable on March 25, 2021 to shareholders of record as of March 11, 2021. In addition, the Company's Board of Directors authorized the repurchase of an aggregate amount of $1.5 billion of Company common stock through the end of 2023. Share repurchases under the Company's program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The Company is not obligated to acquire any shares of its common stock and the share repurchase program may be suspended or terminated at any time at the Company's discretion. Share repurchases are subject to the terms of the Company's debt agreements, market conditions and other factors. The repurchased shares, if any, are expected to be used for the Company's stock-based benefit plans, as required, and to offset dilution resulting from the issuance of shares thereunder. The Board of Directors has the authority to issue, at any time or from time to time, up to 30 million shares of preferred stock and has authority to fix the designations, number and voting rights, preferences, privileges, limitations, restrictions, conversion

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss Attributable to Crown Holdings	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Loss Attributable to Crown Holdings	Accumulated Other Comprehensive Loss Attributable to Crown Holdings The following table provides information about the changes in each component of accumulated other comprehensive income for the years ended December 31, 2020 and 2019. Defined benefit plans Foreign currency translation Gains and losses on cash flow hedges Total Balance at January 1, 2019 $ (1,533) $ (1,817) $ (24) $ (3,374) Other comprehensive income / (loss) before reclassifications 10 149 (22) 137 Amounts reclassified from accumulated other comprehensive income 74 — 32 106 Other comprehensive income 84 149 10 243 Balance at December 31, 2019 (1,449) (1,668) (14) (3,131) Other comprehensive (loss) / income before reclassifications (117) (91) 9 (199) Amounts reclassified from accumulated other comprehensive income 102 — 35 137 Other comprehensive (loss) / income (15) (91) 44 (62) Balance at December 31, 2020 $ (1,464) $ (1,759) $ 30 $ (3,193) See Note M and Note Q

Revenue

Revenue	12 Months Ended
	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue	Revenue For the years ended December 31, 2020 and 2019, the Company recognized revenue as follows: 2020 2019 Revenue recognized over time $ 5,975 $ 5,724 Revenue recognized at a point in time 5,600 5,941 Total $ 11,575 $ 11,665 See Note X for further disaggregation of the Company's revenue. The Company has applied the practical expedient to exclude disclosure of remaining performance obligations as its binding orders typically have a term of one year or less. Contract Assets and Contract Liabilities Contract assets are typically recognized for work in process related to the Company's three-piece printed products. The Company's equipment business may record contract assets or contract liabilities depending on the timing of satisfaction of performance obligations and receipt of consideration from the customer. These equipment contracts, including payment terms, are typically less than one year in duration. Contract assets and liabilities are reported in a net position on a contract-by-contract basis. Net contract assets and liabilities as of December 31 were as follows: 2020 2019 Contract assets included in prepaid and other current assets $ 37 $ 30 Contract liabilities included in accrued liabilities — (5) Net contract assets $ 37 $ 25 For the year ended December 31, 2020, the Company satisfied performance obligations related to contract assets at December 31, 2019 related to the Company's equipment business and European food business and also recorded new contract assets related to work in process for these businesses. For the year ended December 31, 2020, the Company recognized reve nue of $5 rela ted to contract liabilities at December 31, 2019 for performance obligations satisfied during the period.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company’s shareholder-approved stock-based incentive compensation plans provide for the granting of awards in the form of stock options, deferred stock, restricted stock or stock appreciation rights (“SARs”). The awards may be subject to the achievement of certain performance goals as determined by the Compensation Committee designated by the Company’s Board of Directors. There have been no awards of SARs. At December 31, 2020, there were 2.3 million authorized shares available for future awards. Restricted and Deferred Stock Annually, the Company awards shares of restricted stock to certain senior executives in the form of time-vested restricted stock and performance-based shares. The time-vested restricted stock vests ratably over three years. The performance-based share awards are subject to either a market condition or a performance condition. For awards subject to a market condition, the metric is the Company’s Total Shareholder Return (“TSR”), which includes share price appreciation and dividends paid, during the three three The performance-based shares cliff vest at the end of three years. The number of performance-based shares that will ultimately vest is based on the level of performance achieved, ranging between 0% and 200% of the shares originally awarded, and is settled in shares of common stock. Participants who terminate employment because of disability, death or, subject to Company approval, retirement, receive accelerated vesting of their time-vested awards to the date of termination. However, restrictions lapse on performance-based awards, if at all, on the original vesting date. The Company also issues shares of time-vesting restricted stock to U.S. employees and deferred stock to non-U.S. employees which vest ratably over three A summary of restricted and deferred stock activity follows: Number of shares Non-vested shares outstanding at January 1, 2020 2,102,654 Awarded: Time-vesting 286,593 Performance-based 166,018 Released: Time-vesting (447,469) Performance-based (181,705) Forfeitures: Time-vesting (92,681) Performance-based (7,651) Non-vested shares outstanding at December 31, 2020 1,825,759 The average grant-date fair value of restricted stock awarded in 2020, 2019 and 2018 follows: 2020 2019 2018 Time-vested $ 70.07 $ 56.06 $ 44.48 Performance-based 72.08 46.08 57.24 The fair values of the performance-based awards that include a market condition were calculated using a Monte Carlo valuation model and the following weighted average assumptions: 2020 2019 2018 Risk-free interest rate 1.6 % 2.5 % 2.0 % Expected term (years) 3 3 3 Expected stock price volatility 22.0 % 21.4 % 19.9 % At December 31, 2020, unrecognized compensation cost related to outstanding restricted and deferred stock was $62. The weighted average period over which the expense is expected to be recognized is 2.3 years. The aggregate market value of the shares released on the vesting dates was $49 in 2020.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table summarizes basic and diluted earnings per share ("EPS"). Basic EPS excludes all potentially dilutive securities and is computed by dividing net income attributable to Crown Holdings by the weighted average number of common shares outstanding during the period. Diluted EPS includes the effect of stock options and restricted stock as calculated under the treasury stock method. 2020 2019 2018 Net income attributable to Crown Holdings $ 579 $ 510 $ 439 Weighted average shares outstanding (in millions): Basic 133.53 133.89 133.64 Add: dilutive stock options and restricted stock 1.03 0.99 0.24 Diluted 134.56 134.88 133.88 Basic EPS $ 4.34 $ 3.81 $ 3.28 Diluted EPS $ 4.30 $ 3.78 $ 3.28 Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive 0.7 0.8 0.9

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Segment Information	Segment Information The Company’s business is generally organized by product line and geography within four divisions: Americas, Europe, Asia Pacific and Transit Packaging. Within the Americas and European divisions, the Company has determined that it has the following reportable segments: Americas Beverage within the Americas, and European Beverage and European Food within Europe. The Company's Asia Pacific and Transit Packaging Divisions are reportable segments. Other segments include the Company's food can and closures businesses in North America, aerosol can businesses in North America and Europe, its promotional packaging business in Europe, and its beverage tooling and equipment operations in the U.S. and U.K. The Company evaluates performance and allocates resources based on segment income. Segment income, which is not a defined term under GAAP, is defined by the Company as income from operations adjusted to exclude intangibles amortization charges, provisions for asbestos and restructuring and other, the impact of fair value adjustments related to inventory acquired in an acquisition and the timing impact of hedge ineffectiveness. Segment income should not be considered in isolation or as a substitute for net income data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies. The tables below present information about operating segments for the three years ended December 31, 2020, 2019 and 2018: 2020 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,565 $ 2 $ 3,886 $ 93 $ 333 $ 652 European Beverage 1,473 39 1,977 47 72 215 European Food 1,975 95 2,900 37 30 228 Asia Pacific 1,168 — 1,808 56 69 175 Transit Packaging 2,018 13 4,195 45 40 254 Total reportable segments 10,199 149 14,766 278 544 $ 1,524 Other segments 1,376 126 1,134 18 33 Corporate and unallocated items — — 770 5 10 Total $ 11,575 $ 275 $ 16,670 $ 301 $ 587 2019 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,369 $ 12 $ 3,577 $ 88 $ 167 $ 534 European Beverage 1,497 2 1,782 54 82 190 European Food 1,887 81 2,742 36 34 205 Asia Pacific 1,290 — 1,604 52 65 194 Transit Packaging 2,274 9 4,157 57 27 290 Total reportable segments 10,317 104 13,862 287 375 $ 1,413 Other segments 1,348 143 1,106 18 31 Corporate and unallocated items — — 537 4 26 Total $ 11,665 $ 247 $ 15,505 $ 309 $ 432 2018 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,282 $ 53 $ 3,388 $ 84 $ 111 $ 454 European Beverage 1,489 1 1,705 38 121 193 European Food 1,982 69 2,792 39 17 257 Asia Pacific 1,316 — 1,558 48 130 186 Transit Packaging 1,800 5 4,415 43 24 255 Total reportable segments 9,869 128 13,858 252 403 $ 1,345 Other segments 1,282 142 1,066 18 27 Corporate and unallocated items — — 338 7 32 Total $ 11,151 $ 270 $ 15,262 $ 277 $ 462 Intersegment sales primarily include sales of ends and components used to manufacture cans, such as printed and coated metal, as well as parts and equipment used in the manufacturing process. Corporate and unallocated items include corporate and division administrative costs, technology costs, and unallocated items such as stock-based compensation. A reconciliation of segment income of reportable segments to income before income taxes for the three years ended December 31, 2020, 2019 and 2018 follows: 2020 2019 2018 Segment income of reportable segments $ 1,524 $ 1,413 $ 1,345 Segment income of other segments 119 126 122 Corporate and unallocated items (165) (158) (139) Restructuring and other (34) 26 (44) Goodwill impairment — (25) — Amortization of intangibles (180) (186) (148) Loss from early extinguishments of debt — (27) — Fair value adjustment to inventory — — (40) Other pension and postretirement (45) (13) 25 Interest expense (300) (378) (384) Interest income 8 17 21 Foreign exchange (1) (9) (18) Income before income taxes $ 926 $ 786 $ 740 For the three years ended December 31, 2020, 2019 and 2018, intercompany profit of $9, $6 and $7 was eliminated within segment income of other segments. For the three years ended December 31, 2020, 2019 and 2018, no one customer accounted for more than 10% of the Company's consolidated net sales. Sales by major product were: 2020 2019 2018 Metal beverage cans and ends $ 5,716 $ 5,588 $ 5,551 Metal food cans and ends 2,507 2,435 2,452 Transit packaging 2,018 2,274 1,800 Other metal packaging 851 887 884 Other products 483 481 464 Consolidated net sales $ 11,575 $ 11,665 $ 11,151 The following table provides sales and long-lived asset information for the major countries in which the Company operates. Long-lived assets includes property, plant and equipment. Net Sales Long-Lived Assets 2020 2019 2018 2020 2019 United States $ 3,586 $ 3,407 $ 3,018 $ 922 $ 722 Brazil 706 714 732 396 393 Mexico 681 834 763 421 438 Canada 662 508 502 93 73 Spain 597 682 666 384 337 United Kingdom 565 641 685 170 136 Other 4,778 4,879 4,785 1,812 1,788 Consolidated total $ 11,575 $ 11,665 $ 11,151 $ 4,198 $ 3,887

Quarterly Data (unaudited)

Quarterly Data (unaudited)	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Quarterly Data (unaudited)	Quarterly Data (unaudited) (in millions) 2020 2019 First (1) Second (2) Third (3) Fourth (4) First (5) Second (6) Third (7) Fourth (8) Net sales $ 2,757 $ 2,689 $ 3,167 $ 2,962 $ 2,755 $ 3,035 $ 3,084 $ 2,791 Gross profit * 415 417 568 512 423 495 508 400 Income from operations 246 275 406 337 262 383 352 199 Net income (loss) attributable to Crown Holdings 88 126 214 151 103 137 183 87 Earnings per average common share: Basic $ 0.66 $ 0.95 $ 1.61 $ 1.13 $ 0.77 $ 1.02 $ 1.37 $ 0.65 Diluted 0.65 0.94 1.59 1.12 0.77 1.02 1.36 0.64 Average common shares outstanding: Basic 134.1 133.3 133.3 133.5 133.8 133.9 133.9 134.0 Diluted 135.0 134.0 134.4 134.7 134.4 134.8 135.0 135.2 * The Company defines gross profit as net sales less cost of products sold and depreciation and amortization. Notes: (1) Includes pre-tax charges of $7 for restructuring and other and $37 for pension plan settlements. (2) Includes pre-tax charges of $3 for restructuring and other and $19 for pension plan settlements. (3) Includes pre-tax charges of $10 for restructuring and other and $5 for pension plan settlements. (4) Includes pre-tax charges of $14 for restructuring and other and $5 for pension plan settlements. (5) Includes pre-tax charges of $4 for restructuring and other and $6 from early extinguishment of debt and a pension plan curtailment gain of $14. (6) Includes pre-tax gains of $45 for restructuring and other, and charges of $31 for a pension plan settlement and $15 to settle a tax contingency. (7) Includes pre-tax charges of $6 for pension plan settlements. (8) Includes pre-tax charges of $25 for a goodwill impairment, $15 for restructuring and other and $7 for pension plan settlements. Also, includes income tax benefits of $37 primarily related to a deferred tax valuation allowance release.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts and Reserves	12 Months Ended
	Dec. 31, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts and Reserves	SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (In millions) COLUMN A COLUMN B COLUMN C COLUMN D COLUMN E COLUMN F Additions Description Balance at Charged to costs and expense Charged to Acquisitions Deductions Balance at For the year ended December 31, 2020 Allowances deducted from assets to which they apply: Trade accounts receivable $ 62 $ 6 $ — $ — $ (9) $ 59 Deferred tax assets 243 (11) 1 — (28) 205 For the year ended December 31, 2019 Allowances deducted from assets to which they apply: Trade accounts receivable 65 4 — 1 (8) 62 Deferred tax assets 282 (33) 5 — (11) 243 For the year ended December 31, 2018 Allowances deducted from assets to which they apply: Trade accounts receivable 71 (6) (4) 7 (3) 65 Deferred tax assets 228 (1) (7) 76 (14) 282

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Business and Principles of Consolidation	Business and Principles of Consolidation . The consolidated financial statements include the accounts of Crown Holdings, Inc. (the “Company”) and its consolidated subsidiary companies (where the context requires, the “Company” shall include reference to the Company and its consolidated subsidiary companies). The Company is a worldwide leader in the design, manufacture and sale of packaging products and equipment for consumer goods and industrial products. The Company’s packaging for consumer goods include steel and aluminum cans for beverage, food, household and other consumer products, glass bottles for beverage products and metal vacuum closures and steel crowns sold through the Company's sales organization to the soft drink, food, citrus, brewing, household products, personal care and various other industries. The Company's packaging for industrial products includes steel and plastic strap consumables and equipment, paper-based protective packaging, and plastic film consumables and equipment, which are sold into the metals, food and beverage, construction, agricultural, corrugated and general industries. The financial statements were prepared in conformity with accounting principles generally accepted in the United States of America and reflect management’s estimates and assumptions. Actual results could differ from those estimates, impacting reported results of operations and financial position. All intercompany accounts and transactions are eliminated in consolidation. In deciding which entities should be reported on a consolidated basis, the Company first determines whether the entity is a variable interest entity (“VIE”). If an entity is a VIE, the Company determines whether it is the primary beneficiary and therefore, should consolidate the VIE. If an entity is not a VIE, the Company consolidates those entities in which it has control, including certain subsidiaries that are not majority-owned. Certain of the Company’s agreements with noncontrolling interests contain provisions in which the Company would surrender certain decision-making rights upon a change in control of the Company. Accordingly, consolidation of these operations may no longer be appropriate subsequent to a change in control of the Company, as defined in the agreements. Investments in companies in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. Other investments are carried at cost.
Foreign Currency Translation	Foreign Currency Translation . For non-U.S. subsidiaries which operate in a local currency environment, assets and liabilities are translated into U.S. dollars at year-end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the year. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired; all other assets and liabilities are translated at year-end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates; all other income and expense items are translated at average exchange rates prevailing during the year. Gains and losses which result from remeasurement are included in earnings.
Revenue Recognition	Revenue Recognition . On January 1, 2018, the Company adopted new accounting guidance which outlined a single comprehensive model to use in accounting for revenue arising from contracts with customers and superseded previous revenue guidance. Under previous guidance, the Company generally recognized revenue from product sales when the goods were shipped and title and risk of loss passed to the customer. Under the new guidance, revenues are recognized when control of the promised product is transferred to customers. The majority of the Company’s revenues from metal packaging products are derived from multi-year requirement contracts with leading manufacturers and marketers of packaged consumer products for can sets, comprising a can and an end. As requirement contracts do not typically include fixed volumes, customers often purchase products pursuant to purchase orders or other communications which are short-term in nature. The can and the end are considered separate performance obligations because they are distinct and separately identifiable. Revenues from the Company's transit packaging segment are generally derived from individual purchase orders which may include multiple goods and services which are separate performance obligations because they are distinct and separately identifiable. The Company manufactures certain products that have no alternative use to the Company once they are printed or manufactured to customer specifications. If the Company has an enforceable right to payment for custom products at all times in the manufacturing process, revenue is recognized over time. In each of the Company’s geographic markets, revenue from beverage cans is primarily recognized over time using the units produced output method as beverage cans are generally printed for a specific customer in a continuous production process. The timing of revenue recognition for the Company’s other products, including beverage ends and three-piece products, which includes food cans and ends and aerosol cans and ends, may vary as these products may be printed or customized depending upon customer preferences which can vary by geographic market. Revenue that is recognized over time for the Company’s three-piece products and equipment business is generally recognized using the cost-to-cost input method as these products involve an intermediary step that results in customized work-in-process inventory. For products that follow a point in time model, revenue is generally recognized when title and risk of loss transfer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Standalone selling prices for each performance obligation are generally stated in the contract. When the Company offers variable consideration in the form of volume rebates to customers, it estimates the most likely amount of revenue to which it is expected to be entitled and includes the estimate in the transaction price, limited to the amount which is probable will not result in reversal of cumulative revenue recognized when the variable consideration is resolved. When the Company offers customers options to purchase additional product at discounted prices, judgment is required to determine if the discounted prices represent material rights. If so, the transaction price allocated to the discount is based on its relative standalone price and is recognized upon purchase of the additional product. Customer payment terms are typically less than one year and as such, the Company has applied the practical expedient to exclude consideration of significant financing components from the determination of transaction price. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Shipping and handling fees and costs from product sales are reported as cost of products sold and are accrued when the Company recognizes revenue over time before the shipping and handling activities occur. Costs to obtain a contract are generally immaterial but the Company has elected the practical expedient to expense these costs as incurred if the duration of the contract is one year or less. Unbilled receivables are recorded for revenue recognized over time when the Company has determined that control has passed to the customer but the customer has not yet been invoiced because the Company does not have present right to payment. The Company generally has a present right to payment when title of product transfers. Unbilled receivables are included in receivables in the Consolidated Balance Sheet with a corresponding decrease to inventory. Contract assets are recorded for revenue recognized over time when the Company has determined that control for a performance obligation has passed to the customer, but the right to invoice the customer is contingent upon the completion of the performance obligations included in the contract. Contract assets are classified as current as they are expected to be invoiced within one year and may not exceed their net realizable value. Contract liabilities are established if the Company must defer the recognition of a portion of consideration received because it has to satisfy a future obligation. Contract liabilities are classified as current or noncurrent based on when the Company expects to recognize revenue.
Stock-Based Compensation	Stock-Based Compensation . For awards with a service or market condition, compensation expense is recognized over the vesting period on a straight-line basis using the grant date fair value of the award and the estimated number of awards that are expected to vest. For awards with a performance condition, the Company assesses the probability of vesting at each reporting period and adjusts compensation cost based on its probability assessment. The Company’s plans provide for stock awards which may include accelerated vesting upon retirement, disability, or death of eligible employees. The Company considers a stock-based award to be vested when the service period is no longer contingent on the employee providing future service. Accordingly, the related compensation cost is recognized immediately for awards granted to retirement-eligible individuals, or over the period from the grant date to the date that retirement eligibility is achieved if less than the stated vesting period.
Cash and Cash Equivalents	Cash, Cash Equivalents and Restricted Cash. Cash equivalents represent investments with maturities of three months or less from the time of purchase and are carried at cost, which approximates fair value because of the short maturity of those instruments. Outstanding checks in excess of funds on deposit are included in accounts payable.
Restricted Cash	The Company generally classifies any cash that is legally restricted as to withdrawal or usage as restricted cash.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The measurement of expected credit losses is based on past events, historical experience, current conditions and forecasts that affect the collectability of accounts receivable.
Inventory Valuation	Inventory Valuation . Inventories are stated at the lower of cost or net realizable value, with cost principally determined under the first-in, first-out (“FIFO”) or average cost method.
Property, Plant And Equipment	Property, Plant and Equipment . Property, plant and equipment (“PP&E”) is carried at cost less accumulated depreciation and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. Cost of constructed assets includes capitalized interest incurred during the construction and development period. Maintenance and repairs, including labor and material costs for planned major maintenance such as annual production line overhauls, are expensed as incurred. When PP&E is retired or otherwise disposed, the net carrying amount is eliminated with any gain or loss on disposition recognized in earnings at that time. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18
Goodwill and Intangible Assets	Goodwill and Intangible Assets . Assets and liabilities of acquired businesses are recorded under the acquisition method of accounting at their estimated fair values at the dates of acquisition. Goodwill represents costs in excess of fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is carried at cost and reviewed for impairment annually in the fourth quarter of each year or when facts and circumstances indicate goodwill may be impaired. Goodwill was allocated to the reporting units at the time of each acquisition based on the relative fair values of the reporting units. In assessing goodwill for impairment, the Company may first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Further quantitative assessment may then be required. The quantitative assessment involves a number of assumptions and judgments, including the calculation of fair value for the Company’s identified reporting units. The Company determines the estimated fair value of each reporting unit based on an average of the estimated fair values using an income and a market approach. The income approach utilizes significant assumptions, including revenue and Adjusted EBITDA margin growth rates and discount rate. If the carrying value of a reporting unit exceeds its fair value, any impairment loss is measured by comparing the carrying value of the reporting unit to its fair value, not to exceed the carrying amount of goodwill. Definite-lived intangible assets are carried at cost less accumulated amortization. Definite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Definite-lived intangible assets are tested for impairment when facts and circumstances indicate the carrying value may not be recoverable from their undiscounted cash flows. If impaired, the assets are written down to fair value based on either discounted cash flows or appraised values. Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8
Impairment or Disposal of Long-Lived Assets	Impairment or Disposal of Long-Lived Assets . In the event that facts and circumstances indicate that the carrying value of long-lived assets, primarily PP&E, may be impaired, the Company performs a recoverability evaluation. If the evaluation indicates that the carrying value of an asset is not recoverable from its undiscounted cash flows, an impairment loss is measured by comparing the carrying value of the asset to its fair value, based on discounted cash flows. Long-lived assets classified as held for sale are presented in the balance sheet at the lower of their carrying value or fair value less cost to sell.
Leases	Leases. On January 1, 2019, the Company adopted new guidance on lease accounting. Under the guidance, lease classification criteria and income statement recognition were similar to previous guidance; however, all leases with a term longer than one year are recorded on the balance sheet through a right-of-use asset and a corresponding liability. The Company has operating and finance leases for land and buildings related to certain manufacturing facilities, warehouses and corporate offices, vehicle fleets and certain office and manufacturing equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company's lease terms include options to extend the lease when it is reasonably certain that the Company will exercise the option. Variable lease payment amounts that cannot be determined at commencement of the lease, such as increases in index rates, are not included in the measurement of the lease liabilities and corresponding right-of-use assets and are recognized in the period those payments are incurred. The Company separates lease and non-lease components of lease arrangements and allocates contract consideration based on standalone selling prices. Variable consideration is allocated to the lease and non-lease components to which the variable payments specifically relate. The discount rate implicit within the Company's leases is often not determinable and therefore the Company generally uses its incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of the lease payments. The incremental borrowing rate is determined based on lease term and the currency in
Taxes on Income	Taxes on Income . The provision for income taxes is determined using the asset and liability approach. Deferred taxes represent the future expected tax consequences of differences between the financial reporting and tax bases of assets and liabilities based upon enacted tax rates and laws. The Company has made an accounting policy election to treat taxes due on future U.S. inclusions of certain intangible income of foreign subsidiaries as a current period expense when incurred. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Investment tax credits are accounted for using the deferral method. Income tax-related interest and penalties are reported as income tax expense.
Derivatives and Hedging	Derivatives and Hedging . All outstanding derivative financial instruments are recognized in the balance sheet at their fair values. The impact on earnings from recognizing the fair values of these instruments depends on their intended use, their hedge designation and their effectiveness in offsetting changes in the fair values of the exposures they are hedging. Changes in the fair values of instruments designated to reduce or eliminate adverse fluctuations in the fair values of recognized assets and liabilities are reported currently in earnings along with changes in the fair values of the hedged items. Changes in the effective portions of the fair values of instruments used to reduce or eliminate adverse fluctuations in cash flows of anticipated or forecasted transactions are reported in equity as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified to earnings when the related hedged items impact earnings or the anticipated transactions are no longer probable. Changes in the fair values of derivative instruments that are not designated as hedges or do not qualify for hedge accounting treatment are reported currently in earnings. Amounts reported in earnings are classified consistent with the item being hedged. The effectiveness of derivative instruments in reducing risks associated with the hedged exposures is assessed at inception and on an ongoing basis. Time value, a component of an instrument’s fair value, is excluded in assessing effectiveness for fair value hedges, except hedges of firm commitments, and included for cash flow hedges. Hedge accounting is discontinued prospectively when (i) the instrument is no longer effective in offsetting changes in fair value or cash flows of the underlying hedged item, (ii) the instrument expires, is sold, terminated or exercised, or (iii) designating the instrument as a hedge is no longer appropriate. The Company formally documents all relationships between its hedging instruments and hedged items at inception, including its risk management objective and strategy for establishing various hedge relationships. Cash flows from hedging instruments are classified in the Consolidated Statements of Cash Flows consistent with the items being hedged.
Treasury Stock	Treasury Stock . Treasury stock is reported at par value. The excess of fair value over par value is first charged to paid-in capital, if any, and then to retained earnings.
Research and Development	Research and Development . Research, development and engineering costs of $53 in 2020, $55 in 2019, and $51 in 2018 were expensed as incurred and reported in selling and administrative expense in the Consolidated Statements of Operations. Substantially all engineering and development costs are related to developing new products or designing significant improvements to existing products or processes. Costs primarily include employee salaries and benefits and facility costs.
Reclassifications	Reclassifications. Certain reclassifications of prior years’ data have been made to conform to the current year presentation.
Recent Accounting and Reporting Pronouncements	Recent Accounting and Reporting Pronouncements. Recently Adopted Accounting Standards On January 1, 2020, the Company adopted new guidance on the accounting for credit losses on financial instruments. The new guidance introduced an approach, based on expected losses, to estimate credit losses on certain types of financial instruments. The new approach to estimating credit losses applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, net investments in operating leases and off-balance-sheet credit exposures. The guidance did not have a material impact on the Company's consolidated financial statements. On January 1, 2020, the Company adopted new guidance, on a prospective basis, which aligns the accounting for implementation costs incurred in a cloud computing arrangement that is a service arrangement (i.e. hosting arrangement) with the guidance on capitalizing costs for internal use software. The guidance did not have a material impact on the Company's consolidated financial statements. Recently Issued Accounting Standards In December 2019, the FASB issued new guidance to simplify the accounting for income taxes by, among other things, reducing complexity in the interim-period accounting for year-to-date loss limitations and changes in tax laws. The guidance is effective for the Company on January 1, 2021. The Company is currently evaluating the impact of adopting this standard and does not expect the guidance to have a material impact on its consolidated financial statements. In March 2020, the FASB issued guidance which provides optional expedients and exceptions for applying GAAP to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and can be applied through December 31, 2022. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Estimated Useful Lives of PP&E	Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18 2020 2019 Buildings and improvements $ 1,419 $ 1,402 Machinery and equipment 6,166 5,836 Land and improvements 307 298 Construction in progress 514 276 8,406 7,812 Less: accumulated depreciation and amortization (4,208) (3,925) $ 4,198 $ 3,887
Schedule of Gross Carrying Amounts and Accumulated Amortization of Finite-Lived Intangible Assets	Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2020 December 31, 2019 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,661 $ (470) $ 1,191 $ 1,621 $ (331) $ 1,290 Trade names 565 (65) 500 541 (40) 501 Technology 165 (67) 98 158 (41) 117 Long term supply contracts 142 (55) 87 150 (48) 102 Patents 16 (12) 4 14 (9) 5 $ 2,549 $ (669) $ 1,880 $ 2,484 $ (469) $ 2,015

Cash, Cash Equivalents, and R_2

Cash, Cash Equivalents, and Restricted Cash (Tables)	12 Months Ended
	Dec. 31, 2020
Cash and Cash Equivalents [Abstract]
Schedule of Cash, Cash Equivalents and Restricted Cash	Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statement of Cash Flows were as follows: 2020 2019 Cash and cash equivalents $ 1,173 $ 607 Restricted cash included in prepaid expenses and other current assets 64 50 Restricted cash included in other non-current assets 1 6 Total restricted cash 65 56 Total cash, cash equivalents and restricted cash $ 1,238 $ 663

Receivables (Tables)

Receivables (Tables)	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Schedule of Receivables	2020 2019 Accounts receivable $ 1,297 $ 1,162 Less: allowance for credit losses (59) (62) Net trade receivables 1,238 1,100 Unbilled receivables 294 226 Miscellaneous receivables 251 202 $ 1,783 $ 1,528

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2020
Inventory Disclosure [Abstract]
Components of Inventories	2020 2019 Raw materials and supplies $ 1,003 $ 905 Work in process 164 151 Finished goods 506 570 $ 1,673 $ 1,626

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2020 and 2019 were as follows: Americas Beverage European Beverage European Food Transit Packaging Other segments Total Balance at January 1, 2019 $ 842 $ 531 $ 1,291 $ 1,506 $ 272 $ 4,442 Goodwill acquired — — — 8 — 8 Goodwill impairment — — — — (25) (25) Foreign currency translation 23 3 (22) (5) 6 5 Balance at December 31, 2019 865 534 1,269 1,509 253 4,430 Foreign currency translation (26) 26 108 52 3 163 Balance at December 31, 2020 $ 839 $ 560 $ 1,377 $ 1,561 $ 256 $ 4,593 The carrying amount of goodwill at December 31, 2020 and 2019 was net of the following accumulated impairments: Americas Beverage European Beverage European Food Transit Packaging Other Segments Total Accumulated impairments $ 29 $ 73 $ 724 $ — $ 175 $ 1,001

intangible Assets (Tables)

intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Gross Carrying Amounts and Accumulated Amortization of Finite-Lived Intangible Assets	Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2020 December 31, 2019 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,661 $ (470) $ 1,191 $ 1,621 $ (331) $ 1,290 Trade names 565 (65) 500 541 (40) 501 Technology 165 (67) 98 158 (41) 117 Long term supply contracts 142 (55) 87 150 (48) 102 Patents 16 (12) 4 14 (9) 5 $ 2,549 $ (669) $ 1,880 $ 2,484 $ (469) $ 2,015

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18 2020 2019 Buildings and improvements $ 1,419 $ 1,402 Machinery and equipment 6,166 5,836 Land and improvements 307 298 Construction in progress 514 276 8,406 7,812 Less: accumulated depreciation and amortization (4,208) (3,925) $ 4,198 $ 3,887

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2020
Leases [Abstract]
Components of Lease Cost	The components of lease expense for the years ended December 31, 2020 and 2019 were as follows: 2020 2019 Operating lease costs: Operating lease cost $ 52 $ 49 Short-term lease cost 5 4 Total operating lease costs $ 57 $ 53 Finance lease cost: Amortization of right-of-use assets $ 1 $ 1 Total finance lease costs $ 1 $ 1
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows: 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 58 $ 51 Financing cash flows from finance leases 3 15 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 53 $ 33
Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to finance leases was as follows: 2020 2019 Finance leases: Property, plant and equipment $ 28 $ 27 Accumulated depreciation (2) (1) Property, plant and equipment, net $ 26 $ 26 Accrued liabilities $ 2 $ 2 Other non-current liabilities 10 11 Total finance lease liabilities $ 12 $ 13
Maturities of Operating Lease Liabilities	Maturities of lease liabilities as of December 31, 2020 were as follows: Operating Leases Finance Leases 2021 $ 56 $ 2 2022 45 2 2023 33 2 2024 25 2 2025 20 2 Thereafter 99 3 Total lease payments 278 13 Less imputed interest (59) (1) Total $ 219 $ 12 At December 31, 2020, the Company does not have material lease commitments that have not commenced.
Maturities of Finance Lease Liabilities	Maturities of lease liabilities as of December 31, 2020 were as follows: Operating Leases Finance Leases 2021 $ 56 $ 2 2022 45 2 2023 33 2 2024 25 2 2025 20 2 Thereafter 99 3 Total lease payments 278 13 Less imputed interest (59) (1) Total $ 219 $ 12 At December 31, 2020, the Company does not have material lease commitments that have not commenced.
Weighted Average Remaining Lease Term and Discount Schedule	The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2020 2019 Weighted average remaining lease term: Operating leases 9.3 9.5 Finance leases 6.6 7.0 Weighted average discount rate: Operating leases 4.0 % 4.2 % Finance leases 3.4 % 4.1 %

Other Non-Current Assets (Table

Other Non-Current Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Investments, All Other Investments [Abstract]
Components of Other Non-Current Assets	2020 2019 Pension assets $ 532 $ 491 Deferred taxes 242 278 Investments 25 20 Debt issuance costs 13 15 Fair value of derivatives 11 54 Other 79 109 $ 902 $ 967

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Payables and Accruals [Abstract]
Accrued Liabilities	2020 2019 Salaries and employee benefits $ 243 $ 205 Accrued taxes, other than on income 165 139 Income taxes 86 67 Accrued interest 85 82 Fair value of derivatives 29 44 Asbestos liabilities 25 25 Pension and postretirement liabilities 23 29 Restructuring 20 17 Other 497 457 $ 1,173 $ 1,065

Restructuring and Other (Tables

Restructuring and Other (Tables)	12 Months Ended
	Dec. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring Charges by Segment and Type	The Company recorded restructuring and other items as follows: 2020 2019 2018 Restructuring $ 23 $ 22 $ 25 Other costs / (income) 9 (41) (2) Asset impairments and sales 2 (7) (5) Transaction costs — — 26 $ 34 $ (26) $ 44 Restructuring charges by segment were as follows: 2020 2019 2018 Americas Beverage $ — $ 1 $ 4 European Beverage — — 1 European Food — 4 4 Asia Pacific 1 3 5 Transit Packaging 19 6 3 Other segments 3 5 5 Corporate — 3 3 $ 23 $ 22 $ 25 Restructuring charges by type were as follows: 2020 2019 2018 Termination benefits $ 12 $ 18 $ 17 Other exit costs 11 4 8 $ 23 $ 22 $ 25

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Summary of Outstanding Debt	2020 2019 Principal Carrying Principal Carrying outstanding amount outstanding amount Short-term debt $ 121 $ 121 $ 75 $ 75 Long-term debt Senior secured borrowings: Term loan facilities U.S. dollar at LIBOR plus 1.5% due 2024 1,029 1,023 1,100 1,094 Euro at EURIBOR plus 1.5% due 2024 1 387 387 505 504 Senior notes and debentures: €650 at 4.0% due 2022 794 791 729 725 U. S. dollar at 4.50% due 2023 1,000 997 1,000 995 €335 at 2.25% due 2023 409 407 376 372 €550 at 0.75% due 2023 671 666 617 610 €600 at 2.625% due 2024 733 729 673 668 €600 at 3.375% due 2025 733 728 673 667 U.S. dollar at 4.25% due 2026 400 396 400 395 U.S. dollar at 4.75% due 2026 875 865 875 863 U.S. dollar at 7.375% due 2026 350 348 350 348 €500 at 2.875% due 2026 610 603 561 554 U.S. dollar at 7.50% due 2096 40 40 40 40 Other indebtedness in various currencies: Fixed rate with rates in 2020 from 3.9% to 7.8% due through 2026 97 97 39 39 Variable rate with average rates in 2020 from 2.3% to 2.7% due through 2027 13 13 6 6 Total long-term debt 8,141 8,090 7,944 7,880 Less: current maturities (67) (67) (62) (62) Total long-term debt, less current maturities $ 8,074 $ 8,023 $ 7,882 $ 7,818 (1) €317 and €450 at December 31, 2020 and 2019
Schedule of Weighted Average Interest Rates	The weighted average interest rates were as follows: 2020 2019 2018 Short-term debt 1.9 % 2.6 % 1.0 % Revolving credit facilities 2.8 % 3.8 % 3.2 %

Derivative and Other Financia_2

Derivative and Other Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Impact on Accumulated Other Comprehensive Income and Earnings from Changes in Fair Value	The following tables set forth financial information about the impact on accumulated other comprehensive income ("AOCI") and earnings from changes in fair value related to derivative instruments designated as cash flow hedges. Amount of gain / (loss) recognized in AOCI Derivatives designated as cash flow hedges 2020 2019 Foreign exchange $ — $ (8) Interest rate (1) (1) Commodities 10 (13) $ 9 $ (22) Amount of loss reclassified from AOCI into income Derivatives designated as cash flow hedges 2020 2019 Affected line item in the Foreign exchange $ (4) $ (4) Net sales Commodities 18 14 Net sales Foreign exchange (2) (1) Cost of products sold Commodities (60) (52) Cost of products sold (48) (43) Income before taxes 13 11 Provision for income taxes $ (35) $ (32) Net Income
Impact on Earnings from Derivatives Not Designated as Hedges	The following table sets forth the impact on earnings from derivatives not designated as hedges. Pre-tax amount of gain / (loss) recognized in earnings Derivatives not designated as hedges 2020 2019 Affected line item in the Statement of Operations Foreign exchange $ — $ (3) Net sales Foreign exchange — 3 Cost of products sold Foreign exchange 30 (26) Foreign exchange $ 30 $ (26)
Schedule of Impact on Other Comprehensive Income from Changes in Fair Value	The following tables set forth financial information about the impact on accumulated other comprehensive income from changes in the fair value of derivative instruments designated as net investment hedges. Amount of (loss) / gain recognized in AOCI Derivatives designated as net investment hedges 2020 2019 Foreign exchange $ (48) $ 26
Fair Value of Financial Assets and Liabilities on Recurring Basis	The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis. Balance Sheet classification December 31, December 31, 2019 Balance Sheet classification December 31, December 31, 2019 Derivatives designated as hedging instruments Foreign exchange contracts cash flow Other current assets $ 9 $ 10 Accrued liabilities $ 8 $ 15 Other non-current assets — 1 Other non-current liabilities 1 1 Foreign exchange contracts fair value Other current assets 2 1 Accrued liabilities 6 3 Commodities contracts cash flow Other current assets 45 11 Accrued liabilities 11 21 Other non-current assets 4 — Other non-current liabilities — — Interest rate contracts cash flow Other non-current assets — — Other non-current liabilities 2 1 Net investment hedge Other non-current assets 7 51 Other non-current liabilities 20 2 $ 67 $ 74 $ 48 $ 43 Derivatives not designated as hedging instruments Foreign exchange contracts Other current assets $ 9 $ 7 Accrued liabilities $ 4 $ 5 Other non-current assets — 2 Other non-current liabilities — 1 $ 9 $ 9 $ 4 $ 6 Total derivatives $ 76 $ 83 $ 52 $ 49 Fair Value Hedge Carrying Amounts Carrying amount of the hedged assets and liabilities Line item in the Balance Sheet in which the hedged item is included December 31, 2020 December 31, 2019 Receivables, net 11 12 Accrued liabilities 100 83
Offsetting Assets	In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2020 Derivative assets $ 76 $ 11 $ 65 Derivative liabilities 52 11 41 Balance at December 31, 2019 Derivative assets $ 83 $ 16 $ 67 Derivative liabilities 49 16 33
Offsetting Liabilities	In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2020 Derivative assets $ 76 $ 11 $ 65 Derivative liabilities 52 11 41 Balance at December 31, 2019 Derivative assets $ 83 $ 16 $ 67 Derivative liabilities 49 16 33
Notional Values of Outstanding Derivative Instruments in the Consolidated Balance Sheets	The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets were: December 31, 2020 December 31, 2019 Derivatives designated as cash flow hedges: Foreign exchange $ 1,127 $ 1,030 Commodities 248 334 Interest rate 200 200 Derivatives designated as fair value hedges: Foreign exchange 183 142 Derivatives designated as net investment hedges: Foreign exchange 1,075 1,075 Derivatives not designated as hedges: Foreign exchange 722 1,017

Asbestos-Related Liabilities (T

Asbestos-Related Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Liability for Asbestos and Environmental Claims [Abstract]
Summary of Claims Activity	The Company's approximate claims activity for the years ended 2020, 2019 and 2018 was as follows: 2020 2019 2018 Beginning claims 56,000 56,000 55,500 New claims 1,500 2,000 2,000 Settlements or dismissals (1,500) (2,000) (1,500) Ending claims 56,000 56,000 56,000
Summary of Outstanding Asbestos Claims by Year of Exposure and State Filed	In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes by year of exposure and state filed. As of December 31, 2020 and December 31, 2019, the Company's outstanding claims were: 2020 2019 Claimants alleging first exposure after 1964 16,500 16,500 Claimants alleging first exposure before or during 1964 filed in: Texas 13,000 13,000 Pennsylvania 1,500 1,500 Other states that have enacted asbestos legislation 6,000 6,000 Other states 19,000 19,000 Total claims outstanding 56,000 56,000
Summary of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases	As of December 31, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows: 2020 2019 2018 Total claims 23 % 22 % 22 % Pre-1964 claims in states without asbestos legislation 41 % 41 % 41 %

Other Non-Current Liabilities (

Other Non-Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Schedule of Other Non-Current Liabilities	2020 2019 Deferred taxes $ 393 $ 405 Asbestos liabilities 226 248 Postemployment benefits 37 36 Income taxes payable 28 25 Fair value of derivatives 23 5 Environmental 12 12 Finance lease liabilities 10 11 Other 127 115 $ 856 $ 857

Pension and Other Postretirem_2

Pension and Other Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2020
Retirement Benefits [Abstract]
Components of Pension Expense and Benefits Cost	The components of pension expense were as follows: U.S. Plans 2020 2019 2018 Service cost $ 18 $ 15 $ 17 Interest cost 38 50 47 Expected return on plan assets (73) (70) (85) Settlements 3 — — Amortization of actuarial loss 56 55 51 Amortization of prior service cost 1 1 1 Net periodic cost $ 43 $ 51 $ 31 Non-U.S. Plans 2020 2019 2018 Service cost $ 12 $ 15 $ 26 Interest cost 53 71 75 Expected return on plan assets (107) (138) (159) Settlements 63 44 38 Curtailments — (14) — Amortization of actuarial loss 28 38 45 Amortization of prior service credit — (1) (11) Net periodic cost $ 49 $ 15 $ 14 The components of net postretirement benefits cost were as follows: Other Postretirement Benefits 2020 2019 2018 Service cost $ 1 $ 1 $ 4 Interest cost 5 6 6 Amortization of prior service credit (26) (34) (37) Amortization of actuarial loss 4 3 4 Net periodic benefit credit $ (16) $ (24) $ (23)
Schedule of Projected Benefit Obligations, Accumulated Benefit Obligations, Plan Assets and Funded Status	The projected benefit obligations, accumulated benefit obligations, plan assets and funded status of the Company's U.S. and non-U.S. plans were as follows: U.S. Plans Non-U.S. Plans 2020 2019 2020 2019 Projected Benefit Obligations Benefit obligations at January 1 $ 1,440 $ 1,371 $ 3,220 $ 3,102 Service cost 18 15 12 15 Interest cost 38 50 53 71 Plan participants’ contributions — — 2 2 Amendments 1 (1) — — Settlements (7) — (271) (152) Curtailments — — — (18) Actuarial loss 109 133 278 242 Benefits paid (94) (128) (151) (152) Foreign currency translation — — 102 110 Benefit obligations at December 31 $ 1,505 $ 1,440 $ 3,245 $ 3,220 Plan Assets Fair value of plan assets at January 1 $ 1,131 $ 1,012 $ 3,480 $ 3,264 Actual return on plan assets 113 244 334 373 Employer contributions 9 3 18 19 Plan participants’ contributions — — 2 2 Settlements (7) — (271) (152) Acquisitions — — — — Benefits paid (94) (128) (152) (152) Foreign currency translation — — 107 126 Fair value of plan assets at December 31 $ 1,152 $ 1,131 $ 3,518 $ 3,480 Funded status $ (353) $ (309) $ 273 $ 260 Accumulated benefit obligations at December 31 $ 1,445 $ 1,397 $ 3,177 $ 3,182
Information for Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2020 2019 Projected benefit obligations $ 1,505 $ 1,440 Accumulated benefit obligations 1,445 1,397 Fair value of plan assets 1,152 1,131 Non-U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2020 2019 Projected benefit obligations $ 428 $ 399 Accumulated benefit obligations 386 383 Fair value of plan assets 191 187
Schedule of Ranges for Asset Allocation and Summary of Defined Benefit Plan Assets and Accrued Income	The strategic ranges for asset allocation in the U.S. plans are as follows: U.S. equities 39 % to 49 % International equities 12 % to 18 % Fixed income 16 % to 26 % Balanced funds 7 % to 13 % Real estate 7 % to 13 % Investment grade credit 30 % to 100 % Equities 0 % to 30 % Hedge funds 0 % to 10 % Real estate 0 % to 5 % Alternative credit 0 % to 15 % Other 0 % to 20 % 2020 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 157 $ 498 $ 655 Global large cap equity — 9 9 U.S. large cap equity 178 4 182 U.S. mid/small cap equity 301 22 323 Mutual funds – global equity 88 — 88 Mutual funds – U.S. equity 56 — 56 Mutual funds – fixed income 75 — 75 855 533 1,388 Level 2 Government issued debt securities — 298 $ 298 Corporate debt securities 58 647 705 Asset backed securities — 2 2 Structured debt — 1,034 1,034 Insurance contracts — 115 115 Derivatives — 166 166 Investment funds – fixed income — 128 128 Investment funds – global equity — 69 69 58 2,459 2,517 Level 3 Investment funds – real estate 91 181 272 Hedge funds — 2 2 Private equity 5 46 51 Real estate – direct 23 12 35 119 241 360 Total assets in fair value hierarchy 1,032 3,233 4,265 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 112 25 137 Investment funds – global equity — 141 141 Investment funds – emerging markets 7 — 7 Hedge funds — 109 109 119 275 394 Total investments at fair value $ 1,151 $ 3,508 $ 4,659 2019 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 23 $ 190 $ 213 Global large cap equity — 7 7 U.S. large cap equity 155 4 159 U.S. mid/small cap equity 218 27 245 Mutual funds – global equity 144 — 144 Mutual funds – U.S. equity 206 — 206 Mutual funds – fixed income 67 — 67 813 228 1,041 Level 2 Government issued debt securities — 260 $ 260 Corporate debt securities 52 332 384 Asset backed securities — 2 2 Structured debt — 811 811 Insurance contracts — 105 105 Derivatives — 194 194 Investment funds – fixed income — 373 373 Investment funds – global equity — 297 297 Investment funds – emerging markets — 33 33 52 2,407 2,459 Level 3 Investment funds – real estate 96 220 316 Hedge funds — 43 43 Private equity 5 70 75 Real estate – direct 21 9 30 122 342 464 Total assets in fair value hierarchy 987 2,977 3,964 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 102 91 193 Investment funds – global equity 18 78 96 Investment funds – emerging markets 23 — 23 Hedge funds — 328 328 143 497 640 Total investments at fair value $ 1,130 $ 3,474 $ 4,604 (a) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Accrued income excluded from the tables above was as follows: 2020 2019 U.S. plan assets $ 1 $ 1 Non-U.S. plan assets 10 6
Reconciliation of Plan Assets Using Level 3	The following tables reconcile the beginning and ending balances of plan assets measured using significant unobservable inputs (Level 3). Hedge Private Real Total Balance at January 1, 2019 $ 113 $ 103 $ 317 $ 533 Foreign currency translation 4 4 8 16 Asset returns – assets held at reporting date (6) (22) 25 (3) Asset returns – assets sold during the period 7 17 6 30 Purchases, sales and settlements, net (75) (27) (10) (112) Balance at December 31, 2019 43 75 346 464 Foreign currency translation 1 2 7 10 Asset returns – assets held at reporting date 3 6 (15) (6) Asset returns – assets sold during the period (12) (9) 3 (18) Purchases, sales and settlements, net (33) (23) (34) (90) Balance at December 31, 2020 $ 2 $ 51 $ 307 $ 360
Additional Information About Pension Plan Assets Valued Using Net Asset Value	The following table presents additional information about the pension plan assets valued using net asset value as a practical expedient: Fair Value Redemption Frequency Redemption Notice Period Balance at December 31, 2020 Investment funds – fixed income $ 137 Semi-monthly 1- 5 days Investment funds – global equity 141 Monthly 1 - 15 days Investment funds – emerging markets 7 Daily 30 days Hedge funds 109 Monthly 1 - 30 days Balance at December 31, 2019 Investment funds – fixed income $ 193 Semi-monthly 1- 5 days Investment funds – global equity 96 Monthly 1 - 15 days Investment funds – emerging markets 23 Daily 30 days Hedge funds 328 Monthly 1 - 30 days
Schedule of Pension Assets and Liabilities	Pension assets and liabilities included in the Consolidated Balance Sheets were: 2020 2019 Non-current assets $ 532 $ 491 Current liabilities 8 13 Non-current liabilities 610 533
Schedule of Changes in Net Loss and Prior Service Cost/(Credit)	Changes in the net loss and prior service cost (credit) for the Company’s pension plans were: 2020 2019 2018 Net loss Prior Net loss Prior Net loss Prior Balance at January 1 $ 1,808 $ 8 $ 1,962 $ (6) $ 2,057 $ (16) Reclassification to net periodic benefit cost (150) (1) (137) 14 (134) 10 Current year gain / (loss) 118 — (53) — 103 — Amendments — 1 — — — — Foreign currency translation 26 — 36 — (64) — Balance at December 31 $ 1,802 $ 8 $ 1,808 $ 8 $ 1,962 $ (6) Changes in the net loss and prior service credit for the Company’s postretirement benefit plans were: 2020 2019 2018 Net Prior Net Prior Net Prior Balance at January 1 $ 42 $ (72) $ 31 $ (105) $ 49 $ (142) Reclassification to net periodic benefit cost (4) 26 (3) 34 (4) 37 Current year gain / (loss) 7 — 14 — (14) — Amendments — — — (1) — — Balance at December 31 $ 45 $ (46) $ 42 $ (72) $ 31 $ (105)
Schedule of Expected Future Benefit Payments	Expected future benefit payments as of December 31, 2020 are: U.S. Non-U.S. 2021 $ 95 $ 166 2022 97 161 2023 100 159 2024 98 159 2025 93 159 2026 - 2030 429 777 Expected future benefit payments are as follows: Benefit Payments 2021 $ 15 2022 13 2023 12 2024 12 2025 11 2026 - 2030 48
Schedule of Benefit Obligations Weighted Average Actuarial Assumptions	The weighted average actuarial assumptions used to calculate the benefit obligations at December 31 were: U.S. Plans 2020 2019 2018 Discount rate 2.5 % 3.2 % 4.3 % Compensation increase 4.7 % 4.7 % 4.5 % Non-U.S. Plans 2020 2019 2018 Discount rate 1.4 % 2.1 % 2.9 % Compensation increase 3.0 % 3.0 % 3.2 % The weighted average actuarial assumptions used to calculate pension expense for each year were: U.S. Plans 2020 2019 2018 Discount rate - service cost 3.6 % 4.7 % 3.9 % Discount rate - interest cost 2.8 % 3.9 % 3.2 % Compensation increase 4.7 % 4.5 % 4.7 % Long-term rate of return 6.8 % 7.3 % 7.3 % Non-U.S. Plans 2020 2019 2018 Discount rate - service cost 2.6 % 3.0 % 2.6 % Discount rate - interest cost 1.9 % 2.7 % 2.2 % Compensation increase 3.0 % 3.2 % 3.2 % Long-term rate of return 3.3 % 4.3 % 4.4 % Weighted average discount rates used to calculate the benefit obligations at the end of each year and the cost for each year are presented below. 2020 2019 2018 Benefit obligations 2.8 % 3.5 % 4.5 % Service cost 4.1 % 4.8 % 4.9 % Interest cost 3.3 % 4.2 % 4.1 %
Schedule of Changes in Benefit Obligations	Changes in the benefit obligations were: 2020 2019 Benefit obligations at January 1 $ 164 $ 147 Service cost 1 1 Interest cost 5 6 Amendments — 6 Actuarial loss 7 14 Benefits paid (11) (13) Foreign currency translation — 3 Benefit obligations at December 31 $ 166 $ 164
Schedule of Assumed Health Care Cost Trend Rates	The assumed health care cost trend rates at December 31, 2020 were as follows: Health care cost trend rate assumed for 2020 5.2 % Rate that the cost trend rate gradually declines to 4.0 % Year that the rate reaches the rate it is assumed to remain 2035
Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets	Non-U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2020 2019 Projected benefit obligations $ 432 $ 403 Accumulated benefit obligations 389 386 Fair value of plan assets 194 189

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Components of Income Before Income Taxes	The components of income before income taxes were as follows: 2020 2019 2018 U.S. $ 93 $ (3) $ 21 Foreign 833 789 719 $ 926 $ 786 $ 740
Provision for Income Taxes	The provision for income taxes consisted of the following: 2020 2019 2018 Current tax: U.S. federal $ — $ (1) $ (2) State and foreign 211 202 183 $ 211 $ 201 $ 181 Deferred tax: U.S. federal $ 37 $ 16 $ 31 State and foreign (4) (51) 4 33 (35) 35 Total $ 244 $ 166 $ 216
Schedule of U.S. Statutory Federal Income Tax Rate to Pre-tax Income	The provision for income taxes differs from the amount of income tax determined by applying the U.S. statutory federal income tax rate to pre-tax income as a result of the following items: 2020 2019 2018 U.S. statutory rate at 21% $ 194 $ 166 $ 155 Tax on foreign income 30 7 30 U.S. taxes on foreign income, net of credits 14 15 24 Valuation allowance changes (11) (33) (1) Tax contingencies 1 19 (2) Tax law changes 4 (11) 4 Other items, net 12 3 6 Income tax provision $ 244 $ 166 $ 216
Components of Deferred Taxes	The components of deferred taxes at December 31 were: 2020 2019 Assets Liabilities Assets Liabilities Tax carryforwards $ 433 $ — $ 512 $ — Postretirement and postemployment benefits 39 — 40 — Pensions 139 101 176 124 Property, plant and equipment 29 172 23 174 Intangible assets — 385 — 401 Asbestos 61 — 66 — Accruals and other 102 92 88 90 Right of use assets — 42 — 30 Lease liabilities 43 — 30 — Valuation allowances (205) — (243) — Total $ 641 $ 792 $ 692 $ 819
Schedule of Tax Loss and Credit Carryforwards Expiration	Tax carryforwards expire as follows: Year Amount 2021 $ 20 2022 75 2023 12 2024 13 2025 27 Thereafter 141 Unlimited 145
Reconciliation of Unrecognized Tax Benefits	A reconciliation of unrecognized tax benefits follows: 2020 2019 2018 Balance at January 1 $ 41 $ 37 $ 29 Additions related to acquisitions — — 13 Additions for prior year tax positions 1 20 1 Lapse of statute of limitations — (1) (3) Settlements — (15) (2) Foreign currency translation 2 — (1) Balance at December 31 $ 44 $ 41 $ 37

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Summary of Common Share Activity	A summary of common share activity for the years ended December 31 follows (in shares): 2020 2019 2018 Common shares outstanding at January 1 135,577,878 135,173,948 134,275,609 Shares repurchased (1,240,328) (106,388) (92,167) Shares issued upon exercise of employee stock options — 70,000 — Restricted stock issued to employees, net of forfeitures 439,700 416,695 958,672 Shares issued to non-employee directors 23,780 23,623 31,834 Common shares outstanding at December 31 134,801,030 135,577,878 135,173,948

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss Attributable to Crown Holdings (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	The following table provides information about the changes in each component of accumulated other comprehensive income for the years ended December 31, 2020 and 2019. Defined benefit plans Foreign currency translation Gains and losses on cash flow hedges Total Balance at January 1, 2019 $ (1,533) $ (1,817) $ (24) $ (3,374) Other comprehensive income / (loss) before reclassifications 10 149 (22) 137 Amounts reclassified from accumulated other comprehensive income 74 — 32 106 Other comprehensive income 84 149 10 243 Balance at December 31, 2019 (1,449) (1,668) (14) (3,131) Other comprehensive (loss) / income before reclassifications (117) (91) 9 (199) Amounts reclassified from accumulated other comprehensive income 102 — 35 137 Other comprehensive (loss) / income (15) (91) 44 (62) Balance at December 31, 2020 $ (1,464) $ (1,759) $ 30 $ (3,193)

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	For the years ended December 31, 2020 and 2019, the Company recognized revenue as follows: 2020 2019 Revenue recognized over time $ 5,975 $ 5,724 Revenue recognized at a point in time 5,600 5,941 Total $ 11,575 $ 11,665
Net Contract Assets and Liabilities	Net contract assets and liabilities as of December 31 were as follows: 2020 2019 Contract assets included in prepaid and other current assets $ 37 $ 30 Contract liabilities included in accrued liabilities — (5) Net contract assets $ 37 $ 25

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Summary of Restricted and Deferred Stock Activity	A summary of restricted and deferred stock activity follows: Number of shares Non-vested shares outstanding at January 1, 2020 2,102,654 Awarded: Time-vesting 286,593 Performance-based 166,018 Released: Time-vesting (447,469) Performance-based (181,705) Forfeitures: Time-vesting (92,681) Performance-based (7,651) Non-vested shares outstanding at December 31, 2020 1,825,759
Summary of Average Grant-Date Fair Value of Restricted Stock	The average grant-date fair value of restricted stock awarded in 2020, 2019 and 2018 follows: 2020 2019 2018 Time-vested $ 70.07 $ 56.06 $ 44.48 Performance-based 72.08 46.08 57.24
Schedule of Weighted Average Assumptions on Performance-Based Shares	The fair values of the performance-based awards that include a market condition were calculated using a Monte Carlo valuation model and the following weighted average assumptions: 2020 2019 2018 Risk-free interest rate 1.6 % 2.5 % 2.0 % Expected term (years) 3 3 3 Expected stock price volatility 22.0 % 21.4 % 19.9 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Summary of Basic and Diluted Earnings Per Share	The following table summarizes basic and diluted earnings per share ("EPS"). Basic EPS excludes all potentially dilutive securities and is computed by dividing net income attributable to Crown Holdings by the weighted average number of common shares outstanding during the period. Diluted EPS includes the effect of stock options and restricted stock as calculated under the treasury stock method. 2020 2019 2018 Net income attributable to Crown Holdings $ 579 $ 510 $ 439 Weighted average shares outstanding (in millions): Basic 133.53 133.89 133.64 Add: dilutive stock options and restricted stock 1.03 0.99 0.24 Diluted 134.56 134.88 133.88 Basic EPS $ 4.34 $ 3.81 $ 3.28 Diluted EPS $ 4.30 $ 3.78 $ 3.28 Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive 0.7 0.8 0.9

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Information on Operating Segments	The tables below present information about operating segments for the three years ended December 31, 2020, 2019 and 2018: 2020 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,565 $ 2 $ 3,886 $ 93 $ 333 $ 652 European Beverage 1,473 39 1,977 47 72 215 European Food 1,975 95 2,900 37 30 228 Asia Pacific 1,168 — 1,808 56 69 175 Transit Packaging 2,018 13 4,195 45 40 254 Total reportable segments 10,199 149 14,766 278 544 $ 1,524 Other segments 1,376 126 1,134 18 33 Corporate and unallocated items — — 770 5 10 Total $ 11,575 $ 275 $ 16,670 $ 301 $ 587 2019 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,369 $ 12 $ 3,577 $ 88 $ 167 $ 534 European Beverage 1,497 2 1,782 54 82 190 European Food 1,887 81 2,742 36 34 205 Asia Pacific 1,290 — 1,604 52 65 194 Transit Packaging 2,274 9 4,157 57 27 290 Total reportable segments 10,317 104 13,862 287 375 $ 1,413 Other segments 1,348 143 1,106 18 31 Corporate and unallocated items — — 537 4 26 Total $ 11,665 $ 247 $ 15,505 $ 309 $ 432 2018 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,282 $ 53 $ 3,388 $ 84 $ 111 $ 454 European Beverage 1,489 1 1,705 38 121 193 European Food 1,982 69 2,792 39 17 257 Asia Pacific 1,316 — 1,558 48 130 186 Transit Packaging 1,800 5 4,415 43 24 255 Total reportable segments 9,869 128 13,858 252 403 $ 1,345 Other segments 1,282 142 1,066 18 27 Corporate and unallocated items — — 338 7 32 Total $ 11,151 $ 270 $ 15,262 $ 277 $ 462
Reconciliation of Segment Income	A reconciliation of segment income of reportable segments to income before income taxes for the three years ended December 31, 2020, 2019 and 2018 follows: 2020 2019 2018 Segment income of reportable segments $ 1,524 $ 1,413 $ 1,345 Segment income of other segments 119 126 122 Corporate and unallocated items (165) (158) (139) Restructuring and other (34) 26 (44) Goodwill impairment — (25) — Amortization of intangibles (180) (186) (148) Loss from early extinguishments of debt — (27) — Fair value adjustment to inventory — — (40) Other pension and postretirement (45) (13) 25 Interest expense (300) (378) (384) Interest income 8 17 21 Foreign exchange (1) (9) (18) Income before income taxes $ 926 $ 786 $ 740
Summary of Sales by Major Product	Sales by major product were: 2020 2019 2018 Metal beverage cans and ends $ 5,716 $ 5,588 $ 5,551 Metal food cans and ends 2,507 2,435 2,452 Transit packaging 2,018 2,274 1,800 Other metal packaging 851 887 884 Other products 483 481 464 Consolidated net sales $ 11,575 $ 11,665 $ 11,151
Summary of Sales and Long-Lived Assets for the Major Countries	The following table provides sales and long-lived asset information for the major countries in which the Company operates. Long-lived assets includes property, plant and equipment. Net Sales Long-Lived Assets 2020 2019 2018 2020 2019 United States $ 3,586 $ 3,407 $ 3,018 $ 922 $ 722 Brazil 706 714 732 396 393 Mexico 681 834 763 421 438 Canada 662 508 502 93 73 Spain 597 682 666 384 337 United Kingdom 565 641 685 170 136 Other 4,778 4,879 4,785 1,812 1,788 Consolidated total $ 11,575 $ 11,665 $ 11,151 $ 4,198 $ 3,887

Quarterly Data (unaudited) (Tab

Quarterly Data (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Quarterly Data (unaudited)	(in millions) 2020 2019 First (1) Second (2) Third (3) Fourth (4) First (5) Second (6) Third (7) Fourth (8) Net sales $ 2,757 $ 2,689 $ 3,167 $ 2,962 $ 2,755 $ 3,035 $ 3,084 $ 2,791 Gross profit * 415 417 568 512 423 495 508 400 Income from operations 246 275 406 337 262 383 352 199 Net income (loss) attributable to Crown Holdings 88 126 214 151 103 137 183 87 Earnings per average common share: Basic $ 0.66 $ 0.95 $ 1.61 $ 1.13 $ 0.77 $ 1.02 $ 1.37 $ 0.65 Diluted 0.65 0.94 1.59 1.12 0.77 1.02 1.36 0.64 Average common shares outstanding: Basic 134.1 133.3 133.3 133.5 133.8 133.9 133.9 134.0 Diluted 135.0 134.0 134.4 134.7 134.4 134.8 135.0 135.2 * The Company defines gross profit as net sales less cost of products sold and depreciation and amortization. Notes: (1) Includes pre-tax charges of $7 for restructuring and other and $37 for pension plan settlements. (2) Includes pre-tax charges of $3 for restructuring and other and $19 for pension plan settlements. (3) Includes pre-tax charges of $10 for restructuring and other and $5 for pension plan settlements. (4) Includes pre-tax charges of $14 for restructuring and other and $5 for pension plan settlements. (5) Includes pre-tax charges of $4 for restructuring and other and $6 from early extinguishment of debt and a pension plan curtailment gain of $14. (6) Includes pre-tax gains of $45 for restructuring and other, and charges of $31 for a pension plan settlement and $15 to settle a tax contingency. (7) Includes pre-tax charges of $6 for pension plan settlements. (8) Includes pre-tax charges of $25 for a goodwill impairment, $15 for restructuring and other and $7 for pension plan settlements. Also, includes income tax benefits of $37 primarily related to a deferred tax valuation allowance release.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Property, Plant and Equipment) (Details)	12 Months Ended
	Dec. 31, 2020
Land improvements
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	25 years
Buildings and building improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	25 years
Buildings and building improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	40 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	18 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies Goodwill and Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2020
Long term supply contracts
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	15 years
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years
Minimum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	11 years
Minimum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years
Minimum | Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	6 years
Maximum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	18 years
Maximum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	27 years
Maximum | Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Research and Development) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Research, development and engineering costs	$ 53	$ 55	$ 51

Cash, Cash Equivalents, and R_3

Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 1,173	$ 607
Restricted cash included in prepaid expenses and other current assets	64	50
Restricted cash included in other non-current assets	1	6
Total restricted cash	65	56
Total cash, cash equivalents and restricted cash	$ 1,238	$ 663	$ 659	$ 435

Receivables (Schedule of Receiv

Receivables (Schedule of Receivables) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Accounts receivable	$ 1,297	$ 1,162
Less: allowance for credit losses	(59)	(62)
Net trade receivables	1,238	1,100
Unbilled receivables	294	226
Miscellaneous receivables	251	202
Receivables, net	$ 1,783	$ 1,528

Receivables (Schedule of Amount

Receivables (Schedule of Amounts Securitized or Factored) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized	$ 1,270	$ 1,318

Receivables (Narrative) (Detail

Receivables (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Receivables [Abstract]
Expenses related to securitization and factoring facilities	$ 19	$ 23	$ 21

Inventories (Schedule of Invent

Inventories (Schedule of Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 1,003	$ 905
Work in process	164	151
Finished goods	506	570
Total inventories	$ 1,673	$ 1,626

Goodwill (Schedule of Goodwill)

Goodwill (Schedule of Goodwill) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Goodwill [Roll Forward]
Balance at beginning of period		$ 4,430	$ 4,442
Goodwill acquired			8
Goodwill impairment	$ (25)	0	(25)	$ 0
Foreign currency translation		163	5
Balance at end of period	4,430	4,593	4,430	4,442
Accumulated impairments balance	1,001		1,001
Americas Beverage | Operating segments
Goodwill [Roll Forward]
Balance at beginning of period		865	842
Goodwill acquired			0
Goodwill impairment			0
Foreign currency translation		(26)	23
Balance at end of period	865	839	865	842
Accumulated impairments balance	29		29
European Beverage | Operating segments
Goodwill [Roll Forward]
Balance at beginning of period		534	531
Goodwill acquired			0
Goodwill impairment			0
Foreign currency translation		26	3
Balance at end of period	534	560	534	531
Accumulated impairments balance	73		73
European Food | Operating segments
Goodwill [Roll Forward]
Balance at beginning of period		1,269	1,291
Goodwill acquired			0
Goodwill impairment			0
Foreign currency translation		108	(22)
Balance at end of period	1,269	1,377	1,269	1,291
Accumulated impairments balance	724		724
Transit Packaging | Operating segments
Goodwill [Roll Forward]
Balance at beginning of period		1,509	1,506
Goodwill acquired			8
Goodwill impairment			0
Foreign currency translation		52	(5)
Balance at end of period	1,509	1,561	1,509	1,506
Accumulated impairments balance	0		0
Other segments | Operating segments
Goodwill [Roll Forward]
Balance at beginning of period		253	272
Goodwill acquired			0
Goodwill impairment			(25)
Foreign currency translation		3	6
Balance at end of period	253	$ 256	253	$ 272
Accumulated impairments balance	$ 175		$ 175

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Gross	$ 2,549	$ 2,484
Accumulated amortization	(669)	(469)
Net	1,880	2,015
Amortization expense	180	186	$ 148
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2021	180
2022	180
2023	179
2024	166
2025	162
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	1,661	1,621
Accumulated amortization	(470)	(331)
Net	1,191	1,290
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross	565	541
Accumulated amortization	(65)	(40)
Net	500	501
Technology
Finite-Lived Intangible Assets [Line Items]
Gross	165	158
Accumulated amortization	(67)	(41)
Net	98	117
Long term supply contracts
Finite-Lived Intangible Assets [Line Items]
Gross	142	150
Accumulated amortization	(55)	(48)
Net	87	102
Patents
Finite-Lived Intangible Assets [Line Items]
Gross	16	14
Accumulated amortization	(12)	(9)
Net	$ 4	$ 5

Property, Plant and Equipment_2

Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Buildings and improvements	$ 1,419	$ 1,402
Machinery and equipment	6,166	5,836
Land and improvements	307	298
Construction in progress	514	276
Property, plant and equipment, gross	8,406	7,812
Less: accumulated depreciation and amortization	(4,208)	(3,925)
Property, plant and equipment, net	$ 4,198	$ 3,887

Leases (Narrative) (Details)

Leases (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Leases [Abstract]
Operating leases expense			$ 50
Variable operating lease costs	$ 3	$ 3
Interest on finance lease liabilities	$ 1	$ 1

Leases (Components of Lease Exp

Leases (Components of Lease Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating lease costs:
Operating lease cost	$ 52	$ 49
Short-term lease cost	5	4
Total operating lease costs	57	53
Finance lease cost:
Amortization of right-of-use assets	1	1
Total finance lease costs	$ 1	$ 1

Leases (Supplemental Cash Flow

Leases (Supplemental Cash Flow Information Related to Leases) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 58	$ 51
Financing cash flows from finance leases	3	15	$ 0
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 53	$ 33

Leases (Supplemental Balance Sh

Leases (Supplemental Balance Sheet Information Related to Leases) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Finance leases:
Property, plant and equipment	$ 28	$ 27
Accumulated depreciation	(2)	(1)
Property, plant and equipment, net	26	26
Accrued liabilities	2	2
Other non-current liabilities	10	11
Total finance lease liabilities	$ 12	$ 13
Weighted average remaining lease term:
Operating Lease, Weighted Average Remaining Lease Term	9 years 3 months 18 days	9 years 6 months
Finance Lease, Weighted Average Remaining Lease Term	6 years 7 months 6 days	7 years
Weighted average discount rate:
Operating Lease, Weighted Average Discount Rate, Percent	4.00%	4.20%
Finance Lease, Weighted Average Discount Rate, Percent	3.40%	4.10%

Leases (Operating and Finance L

Leases (Operating and Finance Lease Liability Maturity Schedule) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Operating Leases
2021	$ 56
2022	45
2023	33
2024	25
2025	20
Thereafter	99
Total lease payments	278
Less imputed interest	(59)
Total operating lease liabilities	219
Finance Leases
2021	2
2022	2
2023	2
2024	2
2025	2
Thereafter	3
Total lease payments	13
Less imputed interest	(1)
Total finance lease liabilities	$ 12	$ 13

Other Non-Current Assets (Sched

Other Non-Current Assets (Schedule of Other Non-Current Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Investments, All Other Investments [Abstract]
Pension assets	$ 532	$ 491
Deferred taxes	242	278
Investments	25	20
Debt issuance costs	13	15
Fair value of derivatives	11	54
Other	79	109
Other non-current assets	$ 902	$ 967

Accrued Liabilities (Details)

Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Payables and Accruals [Abstract]
Salaries and employee benefits	$ 243	$ 205
Accrued taxes, other than on income	165	139
Income taxes	86	67
Accrued interest	85	82
Fair value of derivatives	29	44
Asbestos liabilities	25	25
Pension and postretirement liabilities	23	29
Restructuring	20	17
Other	497	457
Accrued liabilities	$ 1,173	$ 1,065

Restructuring and Other (Schedu

Restructuring and Other (Schedule of Restructuring and Other Charges) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restructuring and Related Activities [Abstract]
Restructuring	$ 23	$ 22	$ 25
Other costs / (income)	9	(41)	(2)
Asset impairments and sales	2	(7)	(5)
Transaction costs	0	0	26
Restructuring and other	$ 34	$ (26)	$ 44

Restructuring and Other (Narrat

Restructuring and Other (Narrative) (Details) $ in Millions	3 Months Ended							12 Months Ended
	Dec. 31, 2020USD ($)	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)facility
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)	$ 14	$ 10	$ 3	$ 7	$ 15	$ 45	$ 4
Other costs / (income)								$ 9	$ (41)	$ (2)
Gain (loss) on restructuring								(2)	7	$ 5
Number of facilities closed | facility										2
Settled Litigation | Mivisa
Restructuring Cost and Reserve [Line Items]
Litigation settlement expense										$ 2
Gain on settlement of litigation										6
Asia Pacific | CHINA
Restructuring Cost and Reserve [Line Items]
Restructuring accrual	$ 20							20
Impaired assets sales | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring									13
Write-down of carrying value fixed assets
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)										13
Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)									18	12
Termination benefits | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)										5
Headcount Reductions
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)									14
Indirect Taxes Paid
Restructuring Cost and Reserve [Line Items]
Other costs / (income)									50
Pre-Acquisition Related Litigation Settlement
Restructuring Cost and Reserve [Line Items]
Other costs / (income)									7
Restructuring Actions Related to Current And Prior Period
Restructuring Cost and Reserve [Line Items]
Other costs / (income)										$ 8
Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)								$ 19
Fire at production facility | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring									$ (6)

Restructuring and Other (Charge

Restructuring and Other (Charges by Segment and Type) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 23	$ 22	$ 25
Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring	12	18	17
Other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring	11	4	8
Other segments
Restructuring Cost and Reserve [Line Items]
Restructuring	3	5	5
Operating segments | Americas Beverage
Restructuring Cost and Reserve [Line Items]
Restructuring	0	1	4
Operating segments | European Beverage
Restructuring Cost and Reserve [Line Items]
Restructuring	0	0	1
Operating segments | European Food
Restructuring Cost and Reserve [Line Items]
Restructuring	0	4	4
Operating segments | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Restructuring	1	3	5
Operating segments | Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring	19	6	3
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 0	$ 3	$ 3

Debt (Summary of Outstanding De

Debt (Summary of Outstanding Debt) (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2020EUR (€)	Dec. 31, 2019USD ($)	Dec. 31, 2019EUR (€)
Principal outstanding
Short-term debt	$ 121		$ 75
Total long-term debt	8,141		7,944
Less: current maturities	(67)		(62)
Total long-term debt, less current maturities	8,074		7,882
Carrying amount
Short-term debt	121		75
Total long-term debt	8,090		7,880
Less: current maturities	(67)		(62)
Total long-term debt, less current maturities	8,023		7,818
Term loan facilities | U.S. dollar at LIBOR plus 1.5% due 2024
Principal outstanding
Total long-term debt	1,029		1,100
Carrying amount
Total long-term debt	$ 1,023		1,094
Term loan facilities | U.S. dollar at LIBOR plus 1.5% due 2024 | LIBOR
Carrying amount
Basis spread on variable rate (as a percent)	1.50%
Term loan facilities | Euro at EURIBOR Plus One Point Five Percentage Due Two Thousand and Twenty Four
Principal outstanding
Total long-term debt	$ 387		505
Carrying amount
Total long-term debt	$ 387		504
Debt instrument, face amount | €		€ 317		€ 450
Term loan facilities | Euro at EURIBOR Plus One Point Five Percentage Due Two Thousand and Twenty Four | EURIBOR
Carrying amount
Basis spread on variable rate (as a percent)	1.50%
Senior notes and debentures: | €650 at 4.0% due 2022
Principal outstanding
Total long-term debt	$ 794		729
Carrying amount
Total long-term debt	$ 791		725
Debt instrument, face amount | €		€ 650
Debt instrument stated percentage	4.00%	4.00%
Senior notes and debentures: | U. S. dollar at 4.50% due 2023
Principal outstanding
Total long-term debt	$ 1,000		1,000
Carrying amount
Total long-term debt	$ 997		995
Debt instrument stated percentage	4.50%	4.50%
Senior notes and debentures: | €335 at 2.25% due 2023
Principal outstanding
Total long-term debt	$ 409		376
Carrying amount
Total long-term debt	$ 407		372
Debt instrument, face amount | €		€ 335
Debt instrument stated percentage	2.25%	2.25%
Senior notes and debentures: | Euro .75% due 2023
Principal outstanding
Total long-term debt	$ 671		617
Carrying amount
Total long-term debt	$ 666		610
Debt instrument, face amount | €		€ 550
Debt instrument stated percentage	0.75%	0.75%
Senior notes and debentures: | €600 at 2.625% due 2024
Principal outstanding
Total long-term debt	$ 733		673
Carrying amount
Total long-term debt	$ 729		668
Debt instrument, face amount | €		€ 600
Debt instrument stated percentage	2.625%	2.625%
Senior notes and debentures: | €600 at 3.375% due 2025
Principal outstanding
Total long-term debt	$ 733		673
Carrying amount
Total long-term debt	$ 728		667
Debt instrument, face amount | €		€ 600
Debt instrument stated percentage	3.375%	3.375%
Senior notes and debentures: | U.S. dollar at 4.25% due 2026
Principal outstanding
Total long-term debt	$ 400		400
Carrying amount
Total long-term debt	$ 396		395
Debt instrument stated percentage	4.25%	4.25%
Senior notes and debentures: | U.S. dollar at 4.75% due 2026
Principal outstanding
Total long-term debt	$ 875		875
Carrying amount
Total long-term debt	$ 865		863
Debt instrument stated percentage	4.75%	4.75%
Senior notes and debentures: | U.S. dollar at 7.375% due 2026
Principal outstanding
Total long-term debt	$ 350		350
Carrying amount
Total long-term debt	$ 348		348
Debt instrument stated percentage	7.375%	7.375%
Senior notes and debentures: | €500 at 2.875% due 2026
Principal outstanding
Total long-term debt	$ 610		561
Carrying amount
Total long-term debt	$ 603		554
Debt instrument, face amount | €		€ 500
Debt instrument stated percentage	2.875%	2.875%
Senior notes and debentures: | U.S. dollar at 7.50% due 2096
Principal outstanding
Total long-term debt	$ 40		40
Carrying amount
Total long-term debt	$ 40		40
Debt instrument stated percentage	7.50%	7.50%
Other indebtedness, fixed rate
Principal outstanding
Total long-term debt	$ 97		39
Carrying amount
Total long-term debt	$ 97		39
Other indebtedness, fixed rate | Minimum
Carrying amount
Debt instrument stated percentage	3.90%	3.90%
Other indebtedness, fixed rate | Maximum
Carrying amount
Debt instrument stated percentage	7.80%	7.80%
Other indebtedness, variable rate
Principal outstanding
Total long-term debt	$ 13		6
Carrying amount
Total long-term debt	$ 13		$ 6
Average variable rates	2.30%	2.30%
Debt instrument interest rate variable percentage rate range maximum	2.70%

Debt (Narrative) (Details)

Debt (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Debt Instrument [Line Items]
Long-term debt, fair value	$ 8,617	$ 8,410
Borrowings outstanding	8,090	7,880
Aggregate maturities of long term debt excluding unamortized discounts, year one	67
Aggregate maturities of long term debt excluding unamortized discounts, year two	901
Aggregate maturities of long term debt excluding unamortized discounts, year three	2,185
Aggregate maturities of long term debt excluding unamortized discounts, year four	1,966
Aggregate maturities of long term debt excluding unamortized discounts, year five	743
Cash payments for interest	302	362	$ 334
Senior notes and debentures: | U.S. dollar at 4.75% due 2026
Debt Instrument [Line Items]
Borrowings outstanding	865	863
Senior notes and debentures: | €500 at 2.875% due 2026
Debt Instrument [Line Items]
Borrowings outstanding	603	554
Senior notes and debentures: | €335 at 2.25% due 2023
Debt Instrument [Line Items]
Borrowings outstanding	407	372
Senior notes and debentures: | Euro .75% due 2023
Debt Instrument [Line Items]
Borrowings outstanding	666	610
Term loan facilities | U.S. dollar at LIBOR plus 1.5% due 2024
Debt Instrument [Line Items]
Borrowings outstanding	1,023	1,094
Term loan facilities | Euro at EURIBOR Plus One Point Five Percentage Due Two Thousand and Twenty Four
Debt Instrument [Line Items]
Borrowings outstanding	387	$ 504
Revolving Credit Facility
Debt Instrument [Line Items]
Credit facility, available borrowing capacity	1,585
Line of credit facility, maximum borrowing capacity	1,650
Outstanding letters of credit	$ 65
Debt covenant, leverage ratio	5
Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.00%
Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Provisions for letters of credit	$ 310
Basis spread on variable rate (as a percent)	1.55%

Debt (Schedule of Weighted Aver

Debt (Schedule of Weighted Average Interest Rates) (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Short-term debt	1.90%	2.60%	1.00%
Revolving credit facilities	2.80%	3.80%	3.20%

Derivative and Other Financia_3

Derivative and Other Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Objectives for using derivative instruments	The Company’s objective in managing exposure to market risk is to limit the impact on earnings and cash flow.
Net gain to be reclassified to earnings	$ 35
Gain, net of tax, expected to be reclassified to earnings	28
Reclassification of anticipated transactions that were no longer considered probable	0	$ 0
Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on foreign exchange contracts designated as fair value hedges	$ 27	$ 1
Minimum
Derivative Instruments, Gain (Loss) [Line Items]
Contracts outstanding, maturity	1 month
Maximum
Derivative Instruments, Gain (Loss) [Line Items]
Contracts outstanding, maturity	23 months
Cash Flow Hedging | Interest rate
Derivative Instruments, Gain (Loss) [Line Items]
Aggregate notional amount			$ 200
Derivative fixed rate			1.82%

Derivative and Other Financia_4

Derivative and Other Financial Instruments (Accumulated Other Comprehensive Income ("AOCI") and Earnings from Changes in Fair Value Related to Derivative Instruments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	$ 9	$ (22)
Provision for income taxes	13	11
Derivatives qualifying as hedges	(35)	(32)
Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	0	(8)
Foreign exchange | Net sales
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	(4)	(4)
Foreign exchange | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	(2)	(1)
Interest rate
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	(1)	(1)
Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	10	(13)
Amounts of gain/(loss) reclassified from AOCI into income	(48)	(43)
Commodities | Net sales
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	18	14
Commodities | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	$ (60)	$ (52)

Derivative and Other Financia_5

Derivative and Other Financial Instruments (Derivatives Not Designated as Hedges Income Statement) (Details) - Derivatives not designated as hedges - Net Investment Hedging - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	$ 30	$ (26)
Foreign exchange | Net sales
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	0	(3)
Foreign exchange | Cost of products sold
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	0	3
Foreign exchange | Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	$ 30	$ (26)

Derivative and Other Financia_6

Derivative and Other Financial Instruments (Net Investment Hedge Narrative) (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020EUR (€)	May 31, 2019USD ($)	Nov. 30, 2018USD ($)
Derivative [Line Items]
Gain (loss), recognized in OCI	$ 1	$ 27
Gain (loss) on net investment hedge, net of tax	1	27
Carrying amount of hedged net investment	1,359		€ 1,113
Foreign exchange
Derivative [Line Items]
Gain (loss), recognized in OCI	(48)	$ 26
Aggregate notional amount				$ 200	$ 875
Derivative fixed rate					4.75%
Net Investment Hedging | Euro notional value
Derivative [Line Items]
Derivative fixed rate					1.84%
Accumulated Other Comprehensive Loss
Derivative [Line Items]
Gain (loss), recognized in OCI	(33)
Gain (loss) on net investment hedge, net of tax	$ (10)

Derivative and Other Financia_7

Derivative and Other Financial Instruments (Impact on OCI from Changes in Derivative Fair Value) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Amount of gain/(loss) recognized in OCI	$ 1	$ 27
Foreign exchange
Derivative [Line Items]
Amount of gain/(loss) recognized in OCI	$ (48)	$ 26

Derivative and Other Financia_8

Derivative and Other Financial Instruments (Fair Values of Financial Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Derivative assets
Total	$ 76	$ 83
Derivative liabilities
Total	52	49
Level 2
Derivative assets
Total	76	83
Derivative liabilities
Total	52	49
Derivatives designated as hedges: | Other assets | Level 2
Derivative assets
Derivatives designated as hedging instruments	67	74
Derivatives designated as hedges: | Other non-current liabilities | Net investment hedge | Level 2
Derivative assets
Derivatives designated as hedging instruments	20	2
Derivatives designated as hedges: | Other liabilities | Level 2
Derivative assets
Derivatives designated as hedging instruments	48	43
Derivatives not designated as hedges: | Other current assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives not designated as hedging instruments	9	7
Derivatives not designated as hedges: | Other non-current assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives not designated as hedging instruments	0	2
Derivatives not designated as hedges: | Other assets | Level 2
Derivative assets
Derivatives not designated as hedging instruments	9	9
Derivatives not designated as hedges: | Accrued liabilities | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives not designated as hedging instruments	4	5
Derivatives not designated as hedges: | Other non-current liabilities | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives not designated as hedging instruments	0	1
Derivatives not designated as hedges: | Other liabilities | Level 2
Derivative assets
Derivatives not designated as hedging instruments	4	6
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other current assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	9	10
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other current assets | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	45	11
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	1
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current assets | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	4	0
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current assets | Interest rate contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	0
Derivatives in cash flow hedges | Derivatives designated as hedges: | Accrued liabilities | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	8	15
Derivatives in cash flow hedges | Derivatives designated as hedges: | Accrued liabilities | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	11	21
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current liabilities | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	1	1
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current liabilities | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	0
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current liabilities | Interest rate contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	2	1
Derivatives in fair value hedges | Derivatives designated as hedges: | Other current assets | Foreign exchange contracts fair value | Level 2
Derivative assets
Derivatives designated as hedging instruments	2	1
Derivatives in fair value hedges | Derivatives designated as hedges: | Accrued liabilities | Foreign exchange contracts fair value | Level 2
Derivative assets
Derivatives designated as hedging instruments	6	3
Net investment hedge | Derivatives designated as hedges: | Other non-current assets | Level 2
Derivative assets
Derivatives designated as hedging instruments	$ 7	$ 51

Derivative and Other Financia_9

Derivative and Other Financial Instruments (Carrying Amount of Hedged Assets and Liabilities) (Details) - Derivatives designated as hedges - Derivatives in fair value hedges - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Cumulative amount of fair value hedge adjustments included in carrying amounts	$ 4	$ 2
Receivables, net
Derivative [Line Items]
Receivables, net	11	12
Accrued liabilities
Derivative [Line Items]
Accrued liabilities	$ 100	$ 83

Derivative and Other Financi_10

Derivative and Other Financial Instruments (Schedule of Offsetting Derivative Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Derivative assets
Gross amounts recognized in the Balance Sheet	$ 76	$ 83
Gross amounts not offset in the Balance Sheet	11	16
Net amount	65	67
Derivative liabilities
Gross amounts recognized in the Balance Sheet	52	49
Gross amounts not offset in the Balance Sheet	11	16
Net amount	$ 41	$ 33

Derivative and Other Financi_11

Derivative and Other Financial Instruments (Notional Values of Outstanding Derivative Instruments in the Consolidated Balance Sheet) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2019
Derivatives in cash flow hedges | Interest rate
Derivatives, Fair Value [Line Items]
Derivative, notional values			$ 200
Derivatives designated as hedges | Derivatives in cash flow hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	$ 1,127	$ 1,030
Derivatives designated as hedges | Derivatives in cash flow hedges | Commodities
Derivatives, Fair Value [Line Items]
Derivative, notional values	248	334
Derivatives designated as hedges | Derivatives in cash flow hedges | Interest rate
Derivatives, Fair Value [Line Items]
Derivative, notional values	200	200
Derivatives designated as hedges | Derivatives in fair value hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	183	142
Derivatives designated as hedges | Net Investment Hedging | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	1,075	1,075
Derivatives not designated as hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	$ 722	$ 1,017

Asbestos-Related Liabilities (N

Asbestos-Related Liabilities (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)Pending_ClaimClaim	Dec. 31, 2019USD ($)Claim	Dec. 31, 2018USD ($)Claim	Dec. 31, 2017Claim
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Holding period for insulation operations (in days)	90 days
Liability for asbestos and environmental claims, net, payment for claims	$ 21	$ 22	$ 21
Number of inactive claims | Claim	19,000
Percentage of claims that do not specify damages	81.00%
Claims outstanding | Claim	56,000	56,000	56,000	55,500
Accrued asbestos claims and related legal costs	$ 251
Unasserted claims	$ 214
Damage claims less than $5
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	16.00%
Damage claims less than $5 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 5
Damage claims from $5 to less than $100
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	3.00%
Damage claims from $5 to less than $100 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 100
Damage claims from $5 to less than $100 | Minimum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 5
Damage claims less than $25
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	36.00%
Damage claims less than $25 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 25
Damages claims in excess of $100
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 100
Claims outstanding | Pending_Claim	14

Asbestos-Related Liabilities (S

Asbestos-Related Liabilities (Summary of Claims Activity) (Details) - Claim	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Loss Contingency, Pending Claims [Roll Forward]
Beginning claims	56,000	56,000	55,500
New claims	1,500	2,000	2,000
Settlements or dismissals	(1,500)	(2,000)	(1,500)
Ending claims	56,000	56,000	56,000

Asbestos-Related Liabilities _2

Asbestos-Related Liabilities (Summary of Outstanding Claims by Year Of Exposure and State Filed) (Details) - Claim	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	56,000	56,000	56,000	55,500
Claimants alleging first exposure after 1964
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	16,500	16,500
Claimants alleging first exposure before or during 1964 | Texas
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	13,000	13,000
Claimants alleging first exposure before or during 1964 | Pennsylvania
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	1,500	1,500
Claimants alleging first exposure before or during 1964 | Other states that have enacted asbestos legislation
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	6,000	6,000
Claimants alleging first exposure before or during 1964 | Other states
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	19,000	19,000

Asbestos-Related Liabilities _3

Asbestos-Related Liabilities (Summary of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases) (Details)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Total claims
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims alleging serious diseases, percentage	23.00%	22.00%	22.00%
Pre-1964 claims in states without asbestos legislation
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims alleging serious diseases, percentage	41.00%	41.00%	41.00%

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2017	Mar. 31, 2017
PRP Site
Commitments And Contingent Liabilities [Line Items]
Estimated future remediation costs	$ 8
Non- PRP Sites
Commitments And Contingent Liabilities [Line Items]
Estimated future remediation costs	$ 7
Penalty Notification Alleging Misclassification of Importation of Certain Goods into U.S. During 2004-2009 | U.S. Customs and Border Protection
Commitments And Contingent Liabilities [Line Items]
Initial and subsequent penalty assessed		$ 6	$ 18

Other Non-Current Liabilities_2

Other Non-Current Liabilities (Schedule of Other Non-Current Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Other Liabilities Disclosure [Abstract]
Deferred taxes	$ 393	$ 405
Asbestos liabilities	226	248
Postemployment benefits	37	36
Income taxes payable	28	25
Fair value of derivatives	23	5
Environmental	12	12
Finance lease liabilities	10	11
Other	127	115
Other non-current liabilities	$ 856	$ 857

Pension and Other Postretirem_3

Pension and Other Postretirement Benefits (Components of Pension Expense) (Details) - USD ($) $ in Millions	3 Months Ended							12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Amortization of actuarial loss	$ (5)	$ (5)	$ (19)	$ (37)	$ (7)	$ (6)	$ (31)
Other Postretirement Benefits
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost								$ 1	$ 1	$ 4
Interest cost								5	6	6
Amortization of actuarial loss								4	3	4
Amortization of prior service cost								(26)	(34)	(37)
Net periodic cost								(16)	(24)	(23)
U.S. Plans | Pension Plan
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost								18	15	17
Interest cost								38	50	47
Expected return on plan assets								(73)	(70)	(85)
Settlements								3	0	0
Amortization of actuarial loss								56	55	51
Amortization of prior service cost								1	1	1
Net periodic cost								43	51	31
Non-U.S. Plans | Pension Plan
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost								12	15	26
Interest cost								53	71	75
Expected return on plan assets								(107)	(138)	(159)
Settlements								63	44	38
Curtailments								0	(14)	0
Amortization of actuarial loss								28	38	45
Amortization of prior service cost								0	(1)	(11)
Net periodic cost								$ 49	$ 15	$ 14

Pension and Other Postretirem_4

Pension and Other Postretirement Benefits (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Multiemployer plans, additional expense	$ 6	$ 5	$ 5
Actuarial loss	387
Defined benefit plan, benefit obligation, asset returns	268
Amounts of common stock included in plan assets	323	244
Defined benefit plan, estimated employer contributions	22
Total contributions		13
Pension Plan | Non-U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actuarial loss	$ 278	242
Funding level	100.00%
Target funding level period	6 years
Percentage change of risk level commensurate	5.00%
Pension Plan | Non-U.S. Plans | Minimum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Yearly rate of funding level decline	4.00%
Pension Plan | Non-U.S. Plans | Maximum
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Yearly rate of funding level decline	7.00%
Pension Plan | U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actuarial loss	$ 109	133
Other Postretirement Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actuarial loss	$ 7	$ 14

Pension and Other Postretirem_5

Pension and Other Postretirement Benefits (Schedule of Projected and Changes in Benefit Obligations) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Projected Benefit Obligations
Curtailments	$ 14
Actuarial loss		$ 387
Other Postretirement Benefits
Projected Benefit Obligations
Benefit obligations at beginning of period	147	164	$ 147
Service cost		1	1	$ 4
Interest cost		5	6	6
Amendments		0	6
Actuarial loss		7	14
Benefits paid		(11)	(13)
Foreign currency translation		0	3
Benefit obligations at end of period		166	164	147
U.S. Plans | Pension Plan
Projected Benefit Obligations
Benefit obligations at beginning of period	1,371	1,440	1,371
Service cost		18	15	17
Interest cost		38	50	47
Plan participants’ contributions		0	0
Amendments		1	(1)
Settlements		(7)	0
Curtailments		0	0
Actuarial loss		109	133
Benefits paid		(94)	(128)
Foreign currency translation		0	0
Benefit obligations at end of period		1,505	1,440	1,371
Plan Assets
Balance at beginning of period	1,012	1,131	1,012
Actual return on plan assets		113	244
Employer contributions		9	3
Plan participants’ contributions		0	0
Settlements		(7)	0
Acquisitions		0	0
Benefits paid		(94)	(128)
Foreign currency translation		0	0
Balance at end of period		1,152	1,131	1,012
Fair value of plan assets		1,152	1,131
Funded status		(353)	(309)
Accumulated benefit obligations at end of period		1,445	1,397
Non-U.S. Plans | Pension Plan
Projected Benefit Obligations
Benefit obligations at beginning of period	3,102	3,220	3,102
Service cost		12	15	26
Interest cost		53	71	75
Plan participants’ contributions		2	2
Amendments		0	0
Settlements		(271)	(152)
Curtailments		0	(18)
Actuarial loss		278	242
Benefits paid		(151)	(152)
Foreign currency translation		102	110
Benefit obligations at end of period		3,245	3,220	3,102
Plan Assets
Balance at beginning of period	$ 3,264	3,480	3,264
Actual return on plan assets		334	373
Employer contributions		18	19
Plan participants’ contributions		2	2
Settlements		(271)	(152)
Acquisitions		0	0
Benefits paid		(152)	(152)
Foreign currency translation		107	126
Balance at end of period		3,518	3,480	$ 3,264
Fair value of plan assets		191	187
Funded status		273	260
Accumulated benefit obligations at end of period		$ 3,177	$ 3,182

Pension and Other Postretirem_6

Pension and Other Postretirement Benefits (Schedule of Accumulated Benefit Obligations in Excess of Plan Assets) (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 1,505	$ 1,440
Accumulated benefit obligations	1,445	1,397
Fair value of plan assets	1,152	1,131
Non-U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	428	399
Accumulated benefit obligations	386	383
Fair value of plan assets	$ 191	$ 187

Pension and Other Postretirem_7

Pension and Other Postretirement Benefits (Schedule of Projected Benefit Obligations in Excess of Plan Assets) (Details) - Foreign Plan - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 432	$ 403
Accumulated benefit obligations	389	386
Fair value of plan assets	$ 194	$ 189

Pension and Other Postretirem_8

Pension and Other Postretirement Benefits (Summary of Strategic Ranges for Assets Allocation Plan) (Details) - Pension Plan	Dec. 31, 2020
Minimum | U.S. Plans | Equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	39.00%
Minimum | U.S. Plans | International equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	12.00%
Minimum | U.S. Plans | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	16.00%
Minimum | U.S. Plans | Balanced funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.00%
Minimum | U.S. Plans | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.00%
Minimum | Non-U.S. Plans | Equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	0.00%
Minimum | Non-U.S. Plans | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	0.00%
Minimum | Non-U.S. Plans | Investment grade credit
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	30.00%
Minimum | Non-U.S. Plans | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	0.00%
Minimum | Non-U.S. Plans | Alternative credit
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	0.00%
Minimum | Non-U.S. Plans | Other
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	0.00%
Maximum | U.S. Plans | Equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	49.00%
Maximum | U.S. Plans | International equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	18.00%
Maximum | U.S. Plans | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	26.00%
Maximum | U.S. Plans | Balanced funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	13.00%
Maximum | U.S. Plans | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	13.00%
Maximum | Non-U.S. Plans | Equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	30.00%
Maximum | Non-U.S. Plans | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	5.00%
Maximum | Non-U.S. Plans | Investment grade credit
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	100.00%
Maximum | Non-U.S. Plans | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	10.00%
Maximum | Non-U.S. Plans | Alternative credit
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	15.00%
Maximum | Non-U.S. Plans | Other
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	20.00%

Pension and Other Postretirem_9

Pension and Other Postretirement Benefits (Schedule of Defined Benefit Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	$ 360	$ 464	$ 533
Level 3 | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2	43	113
Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	51	75	103
Level 3 | Defined Benefit Plan, Real Estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	307	346	317
Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	137	193
Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	141	96
Fair Value Measured at Net Asset Value Per Share | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	109	328
Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	23
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan fair value of plan assets excluding accrued income	4,659	4,604
Pension Plan | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	4,265	3,964
Pension Plan | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,388	1,041
Pension Plan | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	655	213
Pension Plan | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	9	7
Pension Plan | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	182	159
Pension Plan | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	323	245
Pension Plan | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	88	144
Pension Plan | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	56	206
Pension Plan | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	75	67
Pension Plan | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2,517	2,459
Pension Plan | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	128	373
Pension Plan | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	298	260
Pension Plan | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	705	384
Pension Plan | Level 2 | Asset backed securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2	2
Pension Plan | Level 2 | Structured debt
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,034	811
Pension Plan | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	115	105
Pension Plan | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	166	194
Pension Plan | Level 2 | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	69	297
Pension Plan | Level 2 | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		33
Pension Plan | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	360	464
Pension Plan | Level 3 | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2	43
Pension Plan | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	51	75
Pension Plan | Level 3 | Defined Benefit Plan, Real Estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	35	30
Pension Plan | Level 3 | Defined Benefit Plan, Equity Securities, US
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	272	316
Pension Plan | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	394	640
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	137	193
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	141	96
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	109	328
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	23
Pension Plan | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,152	1,131	1,012
Defined benefit plan fair value of plan assets excluding accrued income	1,151	1,130
Accrued income	1	1
Pension Plan | U.S. Plans | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,032	987
Pension Plan | U.S. Plans | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	855	813
Pension Plan | U.S. Plans | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	157	23
Pension Plan | U.S. Plans | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	178	155
Pension Plan | U.S. Plans | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	301	218
Pension Plan | U.S. Plans | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	88	144
Pension Plan | U.S. Plans | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	56	206
Pension Plan | U.S. Plans | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	75	67
Pension Plan | U.S. Plans | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	58	52
Pension Plan | U.S. Plans | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	58	52
Pension Plan | U.S. Plans | Level 2 | Asset backed securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Structured debt
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		0
Pension Plan | U.S. Plans | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	119	122
Pension Plan | U.S. Plans | Level 3 | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	5	5
Pension Plan | U.S. Plans | Level 3 | Defined Benefit Plan, Real Estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	23	21
Pension Plan | U.S. Plans | Level 3 | Defined Benefit Plan, Equity Securities, US
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	91	96
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	119	143
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	112	102
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	18
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	23
Pension Plan | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	3,518	3,480	$ 3,264
Defined benefit plan fair value of plan assets excluding accrued income	3,508	3,474
Accrued income	10	6
Pension Plan | Non-U.S. Plans | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	3,233	2,977
Pension Plan | Non-U.S. Plans | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	533	228
Pension Plan | Non-U.S. Plans | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	498	190
Pension Plan | Non-U.S. Plans | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	9	7
Pension Plan | Non-U.S. Plans | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	4	4
Pension Plan | Non-U.S. Plans | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	22	27
Pension Plan | Non-U.S. Plans | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | Non-U.S. Plans | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | Non-U.S. Plans | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | Non-U.S. Plans | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2,459	2,407
Pension Plan | Non-U.S. Plans | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	128	373
Pension Plan | Non-U.S. Plans | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	298	260
Pension Plan | Non-U.S. Plans | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	647	332
Pension Plan | Non-U.S. Plans | Level 2 | Asset backed securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2	2
Pension Plan | Non-U.S. Plans | Level 2 | Structured debt
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,034	811
Pension Plan | Non-U.S. Plans | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	115	105
Pension Plan | Non-U.S. Plans | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	166	194
Pension Plan | Non-U.S. Plans | Level 2 | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	69	297
Pension Plan | Non-U.S. Plans | Level 2 | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		33
Pension Plan | Non-U.S. Plans | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	241	342
Pension Plan | Non-U.S. Plans | Level 3 | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2	43
Pension Plan | Non-U.S. Plans | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	46	70
Pension Plan | Non-U.S. Plans | Level 3 | Defined Benefit Plan, Real Estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	12	9
Pension Plan | Non-U.S. Plans | Level 3 | Defined Benefit Plan, Equity Securities, US
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	181	220
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	275	497
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	25	91
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	141	78
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Hedge funds
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	109	328
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	$ 0	$ 0

Pension and Other Postretire_10

Pension and Other Postretirement Benefits (Schedule of Reconciliation of Plan Assets Measured by Significant Unobservable Inputs) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Level 3
Plan Assets
Balance at beginning of period	$ 464	$ 533
Foreign currency translation	10	16
Asset returns – assets held at reporting date	(6)	(3)
Asset returns – assets sold during the period	(18)	30
Purchases, sales and settlements, net	(90)	(112)
Balance at end of period	360	464
Level 3 | Hedge funds
Plan Assets
Balance at beginning of period	43	113
Foreign currency translation	1	4
Asset returns – assets held at reporting date	3	(6)
Asset returns – assets sold during the period	(12)	7
Purchases, sales and settlements, net	(33)	(75)
Balance at end of period	2	43
Level 3 | Private equity
Plan Assets
Balance at beginning of period	75	103
Foreign currency translation	2	4
Asset returns – assets held at reporting date	6	(22)
Asset returns – assets sold during the period	(9)	17
Purchases, sales and settlements, net	(23)	(27)
Balance at end of period	51	75
Level 3 | Defined Benefit Plan, Real Estate
Plan Assets
Balance at beginning of period	346	317
Foreign currency translation	7	8
Asset returns – assets held at reporting date	(15)	25
Asset returns – assets sold during the period	3	6
Purchases, sales and settlements, net	(34)	(10)
Balance at end of period	307	346
Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Plan Assets
Balance at beginning of period	96
Balance at end of period	141	96
Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Plan Assets
Balance at beginning of period	23
Balance at end of period	7	23
Fair Value Measured at Net Asset Value Per Share | Hedge funds
Plan Assets
Balance at beginning of period	328
Balance at end of period	109	328
Fair Value Measured at Net Asset Value Per Share | Investment funds – fixed income
Plan Assets
Balance at beginning of period	193
Balance at end of period	$ 137	$ 193

Pension and Other Postretire_11

Pension and Other Postretirement Benefits (Additional Information About Pension Plan Assets Valued Using Net Asset Value) (Details) - Fair Value Measured at Net Asset Value Per Share - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	$ 137	$ 193
Investment funds – global equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	141	96
Investment funds – emerging markets
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	$ 7	$ 23
Redemption Notice Period	30 days	30 days
Hedge funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	$ 109	$ 328
Minimum | Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	1 day	1 day
Minimum | Investment funds – global equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	1 day	1 day
Minimum | Hedge funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	1 day	1 day
Maximum | Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	5 days	5 days
Maximum | Investment funds – global equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	15 days	15 days
Maximum | Hedge funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	30 days	30 days

Pension and Other Postretire_12

Pension and Other Postretirement Benefits (Schedule of Pension Assets/(Liabilities)) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Retirement Benefits [Abstract]
Non-current assets	$ 532	$ 491
Current liabilities	8	13
Non-current liabilities	$ 610	$ 533

Pension and Other Postretire_13

Pension and Other Postretirement Benefits (Schedule of Changes in Net Loss and Prior Service Cost/(Credit)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Pension Plan
Net loss
Balance at beginning of period	$ 1,808	$ 1,962	$ 2,057
Reclassification to net periodic benefit cost	(150)	(137)	(134)
Current year gain / (loss)	118	(53)	103
Amendments	0	0	0
Foreign currency translation	26	36	(64)
Balance at end of period	1,802	1,808	1,962
Prior service
Balance at beginning of period	8	(6)	(16)
Reclassification to net periodic benefit cost	(1)	14	10
Current year gain / (loss)	0	0	0
Amendments	1	0	0
Foreign currency translation	0	0	0
Balance at end of period	8	8	(6)
Other Postretirement Benefits
Net loss
Balance at beginning of period	42	31	49
Reclassification to net periodic benefit cost	(4)	(3)	(4)
Current year gain / (loss)	7	14	(14)
Amendments	0	0	0
Balance at end of period	45	42	31
Prior service
Balance at beginning of period	(72)	(105)	(142)
Reclassification to net periodic benefit cost	26	34	37
Current year gain / (loss)	0	0	0
Amendments	0	(1)	0
Balance at end of period	$ (46)	$ (72)	$ (105)

Pension and Other Postretire_14

Pension and Other Postretirement Benefits (Schedule of Expected Future Benefit Payments) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Other Postretirement Benefits
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2021	$ 15
2022	13
2023	12
2024	12
2025	11
2026 - 2030	48
Defined Benefit Plan, Expected Future Benefit Payment 2020
2021	15
2022	13
2023	12
2024	12
2025	11
2026 - 2030	$ 48
U.S. Plans | Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2021		$ 95
2022		97
2023		100
2024		98
2025		93
2026 - 2030		429
Defined Benefit Plan, Expected Future Benefit Payment 2020
2021		95
2022		97
2023		100
2024		98
2025		93
2026 - 2030		429
Non-U.S. Plans | Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2021		166
2022		161
2023		159
2024		159
2025		159
2026 - 2030		777
Defined Benefit Plan, Expected Future Benefit Payment 2020
2021		166
2022		161
2023		159
2024		159
2025		159
2026 - 2030		$ 777

Pension and Other Postretire_15

Pension and Other Postretirement Benefits (Assumptions Used) (Details) - Pension Plan	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	2.50%	3.20%	4.30%
Compensation increase	4.70%	4.70%	4.50%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - service cost	3.60%	4.70%	3.90%
Discount rate - interest cost	2.80%	3.90%	3.20%
Compensation increase	4.70%	4.50%	4.70%
Long-term rate of return	6.80%	7.30%	7.30%
Non-U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	1.40%	2.10%	2.90%
Compensation increase	3.00%	3.00%	3.20%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - service cost	2.60%	3.00%	2.60%
Discount rate - interest cost	1.90%	2.70%	2.20%
Compensation increase	3.00%	3.20%	3.20%
Long-term rate of return	3.30%	4.30%	4.40%

Pension and Other Postretire_16

Pension and Other Postretirement Benefits (Schedule of Assumed Health Care Cost Trend Rates) (Details) - Other Postretirement Benefits	Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Health care cost trend rate assumed for 2020	5.20%
Rate that the cost trend rate gradually declines to	4.00%

Pension and Other Postretire_17

Pension and Other Postretirement Benefits (Weighted Average Discount Rates used to Calculate the Benefit Obligations (Details) - Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Defined Benefit Plan Disclosure [Line Items]
Benefit obligations	2.80%	3.50%	4.50%
Service cost	4.10%	4.80%	4.90%
Interest cost	3.30%	4.20%	4.10%

Income Taxes (Components of Inc

Income Taxes (Components of Income Before Income Taxes and Equity Earnings) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]
U.S.	$ 93	$ (3)	$ 21
Foreign	833	789	719
Income before income taxes	$ 926	$ 786	$ 740

Income Taxes (Provision for Inc

Income Taxes (Provision for Income Taxes) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Current tax:
U.S. federal		$ 0	$ (1)	$ (2)
State and foreign		211	202	183
Current tax, total		211	201	181
Deferred tax:
U.S. federal		37	16	31
State and foreign		(4)	(51)	4
Deferred tax, total		33	(35)	35
Total	$ 37	$ 244	$ 166	$ 216

Income Taxes (Effective Income

Income Taxes (Effective Income Tax Reconciliation) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Effective Income Tax Rate Reconciliation, Amount [Abstract]
U.S. statutory rate at 21%			$ 194	$ 166	$ 155
Tax on foreign income			30	7	30
U.S. taxes on foreign income, net of credits			14	15	24
Valuation allowance changes			(11)	(33)	(1)
Tax contingencies		$ 15	1	19	(2)
Tax law changes			4	(11)	4
Other items, net			12	3	6
Total	$ 37		$ 244	$ 166	$ 216

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2019	Jun. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Taxes [Line Items]
Taxes paid			$ 189	$ 173	$ 177
Provision for income taxes	$ 37		244	166	216
Tax contingencies		$ 15	1	19	(2)
Charge related to local taxes on distributions of foreign earnings previously asserted to be indefinitely reinvested					24
Deferred taxes on earnings of foreign subsidiaries	1,500			1,500
Valuation allowance	$ 243		205	243
Unrecognized tax benefits, interest and penalties excluded from reserves			2
Interest and penalties expenses			1	1	1
Unrecognized tax benefits that if recognized would affect ETR			44
Signode
Income Taxes [Line Items]
Tax loss carryforwards			39
INDIA
Income Taxes [Line Items]
Tax contingencies				9
Brazil
Income Taxes [Line Items]
Increase in net income attributable to the Company resulting from incentives			17	17	$ 14
Signode
Income Taxes [Line Items]
Tax contingencies				$ 15
U.S.
Income Taxes [Line Items]
Tax loss carryforwards			63
State
Income Taxes [Line Items]
Tax loss carryforwards			115
Valuation allowance			171
France
Income Taxes [Line Items]
Tax loss carryforwards			69
Internal Reorganization
Income Taxes [Line Items]
Provision for income taxes			$ 36

Income Taxes (Components of Def

Income Taxes (Components of Deferred Taxes) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Assets
Tax carryforwards	$ 433	$ 512
Postretirement and postemployment benefits	39	40
Pensions	139	176
Property, plant and equipment	29	23
Intangible assets	0	0
Asbestos	61	66
Accruals and other	102	88
Lease liabilities	43	30
Valuation allowances	(205)	(243)
Total	641	692
Liabilities
Tax carryforwards	0	0
Postretirement and postemployment benefits	0	0
Pensions	101	124
Property, plant and equipment	172	174
Intangible assets	385	401
Asbestos	0	0
Accruals and other	92	90
Right of use assets	42	30
Total	$ 792	$ 819

Income Taxes (Tax Loss and Cred

Income Taxes (Tax Loss and Credit Carryforwards Expirations) (Details) $ in Millions	Dec. 31, 2020USD ($)
Income Tax Disclosure [Abstract]
2021	$ 20
2022	75
2023	12
2024	13
2025	27
Thereafter	141
Unlimited	$ 145

Income Taxes (Reconciliation of

Income Taxes (Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of period	$ 41	$ 37	$ 29
Additions related to acquisitions	0	0	13
Additions for prior year tax positions	1	20	1
Lapse of statute of limitations	0	(1)	(3)
Settlements	0	(15)	(2)
Foreign currency translation, decrease	2	0
Foreign currency translation			(1)
Balance at end of period	$ 44	$ 41	$ 37

Capital Stock (Summary of Commo

Capital Stock (Summary of Common Stock Activity) (Details) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares outstanding at beginning of period (in shares)	135,577,878	135,173,948	134,275,609
Shares repurchased (in shares)	(1,240,328)	(106,388)	(92,167)
Shares issued upon exercise of employee stock options (in shares)	0	70,000	0
Common shares outstanding at end of period (in shares)	134,801,030	135,577,878	135,173,948
Restricted stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued to employees, net of forfeitures (in shares)	439,700	416,695	958,672
Share-based Payment Arrangement | Share-based Payment Arrangement, Nonemployee
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued to employees, net of forfeitures (in shares)	23,780	23,623	31,834

Capital Stock (Narrative) (Deta

Capital Stock (Narrative) (Details) - USD ($) $ / shares in Units, $ in Billions	Feb. 25, 2021	Dec. 31, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)		30,000,000	30,000,000
Subsequent Event
Class of Stock [Line Items]
Common stock, dividends, per share, declared	$ 0.20
Stock repurchase program, authorized amount	$ 1.5

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss Attributable to Crown Holdings (Schedule of AOCI) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	$ 2,092	$ 1,286
Other comprehensive (loss) / income before reclassifications	(199)	137
Amounts reclassified from accumulated other comprehensive income	137	106
Other comprehensive income	(62)	243
Balance at end of period	2,604	2,092
Defined benefit plans
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(1,449)	(1,533)
Other comprehensive (loss) / income before reclassifications	(117)	10
Amounts reclassified from accumulated other comprehensive income	102	74
Other comprehensive income	(15)	84
Balance at end of period	(1,464)	(1,449)
Foreign currency translation
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(1,668)	(1,817)
Other comprehensive (loss) / income before reclassifications	(91)	149
Amounts reclassified from accumulated other comprehensive income	0	0
Other comprehensive income	(91)	149
Balance at end of period	(1,759)	(1,668)
Gains and losses on cash flow hedges
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(14)	(24)
Other comprehensive (loss) / income before reclassifications	9	(22)
Amounts reclassified from accumulated other comprehensive income	35	32
Other comprehensive income	44	10
Balance at end of period	30	(14)
Accumulated Other Comprehensive Loss
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(3,131)	(3,374)
Balance at end of period	$ (3,193)	$ (3,131)

Revenue (Narrative) (Details)

Revenue (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized	$ 2,962	$ 3,167	$ 2,689	$ 2,757	$ 2,791	$ 3,084	$ 3,035	$ 2,755	$ 11,575	$ 11,665	$ 11,151
Revenue recognized related to contract liabilities										5
Transferred over Time
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized									5,975	5,724
Transferred at Point in Time
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized									$ 5,600	$ 5,941

Revenue (Contracts with Custome

Revenue (Contracts with Customer Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Contract assets included in prepaid and other current assets	$ 37	$ 30
Contract liabilities included in accrued liabilities	0	(5)
Net contract assets	$ 37	$ 25

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	2.3
Time-vested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years) for shares awarded	3 years
Performance-based shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years) for shares awarded	3 years
Award vesting period	3 years
Level of performance achieved based on shares awarded, minimum	0.00%
Level of performance achieved based on shares awarded, maximum	200.00%
Time-vested restricted stock and deferred stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Time-vested restricted stock and deferred stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 62
Weighted average recognition period, in years	2 years 3 months 18 days
Aggregate market value of the shares released and issued on the vesting dates		$ 49

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary of Restricted Stock Transactions) (Details)	12 Months Ended
	Dec. 31, 2020shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested shares outstanding at beginning of period (in shares)	2,102,654
Non-vested shares outstanding at end of period (in shares)	1,825,759
Time-vesting
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	286,593
Released (in shares)	(447,469)
Forfeitures (in shares)	(92,681)
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	166,018
Released (in shares)	(181,705)
Forfeitures (in shares)	(7,651)

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of Grant Date Fair Value of Restricted Stock) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Time-vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average grant-date fair value of restricted stock awarded (in usd per share)	$ 70.07	$ 56.06	$ 44.48
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average grant-date fair value of restricted stock awarded (in usd per share)	$ 72.08	$ 46.08	$ 57.24

Stock-Based Compensation (Fair

Stock-Based Compensation (Fair Value Assumptions) (Details) - Performance-based shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.60%	2.50%	2.00%
Expected term (years)	3 years	3 years	3 years
Expected stock price volatility	22.00%	21.40%	19.90%

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Earnings Per Share [Abstract]
Net income attributable to Crown Holdings	$ 151	$ 214	$ 126	$ 88	$ 87	$ 183	$ 137	$ 103	$ 579	$ 510	$ 439
Weighted average shares outstanding (in millions):
Basic (in shares)	133,500	133,300	133,300	134,100	134,000	133,900	133,900	133,800	133,530	133,890	133,640
Add: dilutive stock options and restricted stock (in shares)									1,030	990	240
Diluted (in shares)	134,700	134,400	134,000	135,000	135,200	135,000	134,800	134,400	134,560	134,880	133,880
Basic EPS (in dollars per share per share)	$ 1.13	$ 1.61	$ 0.95	$ 0.66	$ 0.65	$ 1.37	$ 1.02	$ 0.77	$ 4.34	$ 3.81	$ 3.28
Diluted EPS (in dollars per share)	$ 1.12	$ 1.59	$ 0.94	$ 0.65	$ 0.64	$ 1.36	$ 1.02	$ 0.77	$ 4.30	$ 3.78	$ 3.28
Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive (in shares)									700	800	900

Segment Information (Informatio

Segment Information (Information About Operating Segments) (Details) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020USD ($)	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2020USD ($)division	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Segment Reporting Information [Line Items]
Number of geographical divisions | division									4
Net sales	$ 2,962	$ 3,167	$ 2,689	$ 2,757	$ 2,791	$ 3,084	$ 3,035	$ 2,755	$ 11,575	$ 11,665	$ 11,151
Segment assets	16,670				15,505				16,670	15,505	15,262
Depreciation									301	309	277
Capital expenditures									587	432	462
Segment income	337	$ 406	$ 275	$ 246	199	$ 352	$ 383	$ 262	1,264	1,196	1,096
Operating segments
Segment Reporting Information [Line Items]
Net sales									10,199	10,317	9,869
Segment assets	14,766				13,862				14,766	13,862	13,858
Depreciation									278	287	252
Capital expenditures									544	375	403
Segment income									1,524	1,413	1,345
Operating segments | Americas Beverage
Segment Reporting Information [Line Items]
Net sales									3,565	3,369	3,282
Segment assets	3,886				3,577				3,886	3,577	3,388
Depreciation									93	88	84
Capital expenditures									333	167	111
Segment income									652	534	454
Operating segments | European Beverage
Segment Reporting Information [Line Items]
Net sales									1,473	1,497	1,489
Segment assets	1,977				1,782				1,977	1,782	1,705
Depreciation									47	54	38
Capital expenditures									72	82	121
Segment income									215	190	193
Operating segments | European Food
Segment Reporting Information [Line Items]
Net sales									1,975	1,887	1,982
Segment assets	2,900				2,742				2,900	2,742	2,792
Depreciation									37	36	39
Capital expenditures									30	34	17
Segment income									228	205	257
Operating segments | Asia Pacific
Segment Reporting Information [Line Items]
Net sales									1,168	1,290	1,316
Segment assets	1,808				1,604				1,808	1,604	1,558
Depreciation									56	52	48
Capital expenditures									69	65	130
Segment income									175	194	186
Operating segments | Transit Packaging
Segment Reporting Information [Line Items]
Net sales									2,018	2,274	1,800
Segment assets	4,195				4,157				4,195	4,157	4,415
Depreciation									45	57	43
Capital expenditures									40	27	24
Segment income									254	290	255
Intersegment sales
Segment Reporting Information [Line Items]
Net sales									275	247	270
Intersegment sales | Reportable segments
Segment Reporting Information [Line Items]
Net sales									149	104	128
Intersegment sales | Americas Beverage
Segment Reporting Information [Line Items]
Net sales									2	12	53
Intersegment sales | European Beverage
Segment Reporting Information [Line Items]
Net sales									39	2	1
Intersegment sales | European Food
Segment Reporting Information [Line Items]
Net sales									95	81	69
Intersegment sales | Asia Pacific
Segment Reporting Information [Line Items]
Net sales									0	0	0
Intersegment sales | Transit Packaging
Segment Reporting Information [Line Items]
Net sales									13	9	5
Intersegment sales | Other segments
Segment Reporting Information [Line Items]
Net sales									126	143	142
Other segments | Other segments
Segment Reporting Information [Line Items]
Net sales									1,376	1,348	1,282
Segment assets	1,134				1,106				1,134	1,106	1,066
Depreciation									18	18	18
Capital expenditures									33	31	27
Segment income									119	126	122
Corporate and unallocated items
Segment Reporting Information [Line Items]
Net sales									0	0	0
Segment assets	$ 770				$ 537				770	537	338
Depreciation									5	4	7
Capital expenditures									$ 10	$ 26	$ 32

Segment Information (Reconcilia

Segment Information (Reconciliation of Segment Income) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment income	$ 337	$ 406	$ 275	$ 246	$ 199	$ 352	$ 383	$ 262	$ 1,264	$ 1,196	$ 1,096
Restructuring and other									(34)	26	(44)
Goodwill impairment					$ (25)				0	(25)	0
Amortization of intangibles									(180)	(186)	(148)
Loss from early extinguishments of debt									0	(27)	0
Fair value adjustment to inventory									0	0	(40)
Other pension and postretirement									(45)	(13)	25
Interest expense									(300)	(378)	(384)
Interest income									8	17	21
Foreign exchange									(1)	(9)	(18)
Income before income taxes									926	786	740
Intercompany profit related to non-reportable segments									9	6	7
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment income									1,524	1,413	1,345
Operating segments | Other segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Goodwill impairment										(25)
Other segments | Other segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment income									119	126	122
Corporate and unallocated items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Corporate and unallocated items									$ (165)	$ (158)	$ (139)

Segment Information (Summary of

Segment Information (Summary of Sales by Major Product) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Revenue recognized	$ 2,962	$ 3,167	$ 2,689	$ 2,757	$ 2,791	$ 3,084	$ 3,035	$ 2,755	$ 11,575	$ 11,665	$ 11,151
Metal beverage cans and ends
Segment Reporting Information [Line Items]
Revenue recognized									5,716	5,588	5,551
Metal food cans and ends
Segment Reporting Information [Line Items]
Revenue recognized									2,507	2,435	2,452
Transit Packaging
Segment Reporting Information [Line Items]
Revenue recognized									2,018	2,274	1,800
Other metal packaging
Segment Reporting Information [Line Items]
Revenue recognized									851	887	884
Other products
Segment Reporting Information [Line Items]
Revenue recognized									$ 483	$ 481	$ 464

Segment Information (Summary _2

Segment Information (Summary of Sales and Long-Lived Assets for The Major Countries) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Net sales	$ 2,962	$ 3,167	$ 2,689	$ 2,757	$ 2,791	$ 3,084	$ 3,035	$ 2,755	$ 11,575	$ 11,665	$ 11,151
Long-Lived Assets	4,198				3,887				4,198	3,887
United States
Segment Reporting Information [Line Items]
Net sales									3,586	3,407	3,018
Long-Lived Assets	922				722				922	722
Brazil
Segment Reporting Information [Line Items]
Net sales									706	714	732
Long-Lived Assets	396				393				396	393
Mexico
Segment Reporting Information [Line Items]
Net sales									681	834	763
Long-Lived Assets	421				438				421	438
Canada
Segment Reporting Information [Line Items]
Net sales									662	508	502
Long-Lived Assets	93				73				93	73
Spain
Segment Reporting Information [Line Items]
Net sales									597	682	666
Long-Lived Assets	384				337				384	337
Canada
Segment Reporting Information [Line Items]
Net sales									565	641	685
Long-Lived Assets	170				136				170	136
Other
Segment Reporting Information [Line Items]
Net sales									4,778	4,879	$ 4,785
Long-Lived Assets	$ 1,812				$ 1,788				$ 1,812	$ 1,788

Quarterly Data (unaudited) (Det

Quarterly Data (unaudited) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net sales	$ 2,962	$ 3,167	$ 2,689	$ 2,757	$ 2,791	$ 3,084	$ 3,035	$ 2,755	$ 11,575	$ 11,665	$ 11,151
Gross profit	512	568	417	415	400	508	495	423
Income from operations	337	406	275	246	199	352	383	262	1,264	1,196	1,096
Net income (loss) attributable to Crown Holdings	$ 151	$ 214	$ 126	$ 88	$ 87	$ 183	$ 137	$ 103	$ 579	$ 510	$ 439
Earnings per average common share:
Basic (in dollars per share)	$ 1.13	$ 1.61	$ 0.95	$ 0.66	$ 0.65	$ 1.37	$ 1.02	$ 0.77	$ 4.34	$ 3.81	$ 3.28
Diluted (in dollars per share)	$ 1.12	$ 1.59	$ 0.94	$ 0.65	$ 0.64	$ 1.36	$ 1.02	$ 0.77	$ 4.30	$ 3.78	$ 3.28
Average common shares outstanding:
Basic (in shares)	133,500	133,300	133,300	134,100	134,000	133,900	133,900	133,800	133,530	133,890	133,640
Diluted (in shares)	134,700	134,400	134,000	135,000	135,200	135,000	134,800	134,400	134,560	134,880	133,880
Restructuring charges (benefit)	$ 14	$ 10	$ 3	$ 7	$ 15		$ 45	$ 4
Pension and postretirement gain (loss)	$ 5	$ 5	$ 19	$ 37	7	$ 6	31
Loss from early extinguishments of debt								(6)	$ 0	$ 27	$ 0
Curtailments								$ 14
Tax contingencies							$ 15		1	19	(2)
Goodwill impairment					25				0	25	0
Income tax (benefit) expense					$ 37				$ 244	$ 166	$ 216

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts and Reserves (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Trade accounts receivable
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 62	$ 65	$ 71
Charged to costs and expense	6	4	(6)
Charged to other  accounts	0	0	(4)
Acquisitions	0	1	7
Deductions – write-offs	(9)	(8)	(3)
Balance at end of period	59	62	65
Deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	243	282	228
Charged to costs and expense	(11)	(33)	(1)
Charged to other  accounts	1	5	(7)
Acquisitions	0	0	76
Deductions – write-offs	(28)	(11)	(14)
Balance at end of period	$ 205	$ 243	$ 282